All articles tagged: Dermatology
![]()
HealthDay
02 July at 04.01 PM
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 MillionThe mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are considered, according to a study published online June 28 in JAMA Network Open.Aylin Sertkaya, Ph.D., from Eastern Research Group Inc., in Lexington, Massachusetts, and colleagues ass |
![]()
HealthDay
01 July at 03.16 PM
Psoriasis, With or Without Psoriatic Arthritis, Associated With FatiguePsoriasis is associated with fatigue, especially among those with psoriatic arthritis (PsA), according to a study published in the July issue of the Journal of the American Academy of Dermatology.Lea Nymand, from Bispebjerg Hospital and the University of Copenhagen in Denmark, and colleagues explored the characteristics of fatigue and it |
![]()
HealthDay
01 July at 03.04 PM
Few Patients With Positive Margins After Basal Cell Excision Have RecurrenceAmong patients with incompletely excised basal cell carcinoma (BCC), only about 16 percent with positive histopathologic margins have clinical recurrence, according to a study published online June 13 in Dermatology.Maria Daviti, M.D., from Aristotle University in Thessaloniki, Greece, and colleagues reported the real-life management of |
![]()
HealthDay
25 June at 09.42 PM
Abrocitinib Effective, Tolerated for Prurigo Nodularis, Chronic PruritusFor patients with prurigo nodularis (PN) and chronic pruritus of unknown origin (CPUO), abrocitinib, a Janus kinase 1 inhibitor, is effective and well tolerated, according to a study published online June 5 in JAMA Dermatology.Shawn G. Kwatra, M.D., from the University of Maryland School of Medicine in Baltimore, and colleagues examine |
![]()
HealthDay
24 June at 03.02 PM
Nonsignificant Survival Benefit Seen for Dabrafenib, Trametinib in MelanomaFor patients with resected stage III melanoma, adjuvant therapy with dabrafenib plus trametinib is associated with a nonsignificant benefit in terms of overall survival, according to a study published online June 19 in the New England Journal of Medicine.Georgina V. Long, M.D., Ph.D., from the University of Sydney, and colleagues random |
![]()
HealthDay
20 June at 08.56 PM
2021 to 2022 Saw Decrease in Telemedicine Use in Past 12 MonthsFrom 2021 to 2022, there was a decrease in the percentage of adults who used telemedicine in the past 12 months, according to the June 20 National Vital Statistics Reports, a publication from the National Center for Health Statistics.Jacqueline W. Lucas, M.P.H., and Xun Wang, from the National Center for Health Statistics in Hyattsvil |
![]()
HealthDay
18 June at 09.11 PM
Approximately 7 Percent of U.S. Population Uninsured in 2023In 2023, 7.6 percent of the U.S. civilian noninstitutionalized population was uninsured, according to early estimates from the National Health Interview Survey, 2023, released by the National Center for Health Statistics.Robin A. Cohen, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues used data from |
![]()
HealthDay
18 June at 03.44 PM
Lebrikizumab Tied to Sustained Atopic Dermatitis Treatment EffectLebrikizumab is associated with sustained effects for moderate-to-severe atopic dermatitis for up to week 52 following withdrawal of treatment, according to a study presented at the annual Revolutionizing Atopic Dermatitis Conference, held from June 8 to 10 in Chicago.Jonathan I. Silverberg, M.D., Ph.D., M.P.H., from the George Washington Unive |
![]()
HealthDay
18 June at 09.50 AM
Pandemic-Era Tax Credits Made Healthcare More Affordable, But They're Set to ExpireIn a success story for Americans seeking affordable healthcare coverage, tax credits put in place during the pandemic helped millions gain health insurance, a new report found.Trouble is, the credits are set to expire at the end of 2025, noted a research team from the nonprofit Robert Wood Johnson Foundation (RWJ).According to RWJ's <a h |
![]()
HealthDay
14 June at 03.32 PM
No Evidence That Live Vaccines Are Unsafe for Patients on DupilumabThere is no evidence to suggest that administration of live vaccines to patients receiving dupilumab is unsafe, and vaccine efficacy is not affected by dupilumab, according to a position paper published online June 5 in the Annals of Allergy, Asthma & Immunology.Noting that dupilumab targets the interleukin (IL)-4 receptor alpha sub |
![]()
HealthDay
13 June at 10.58 PM
Health Care Spending Growth Projected to Outpace GDP to 2032Health care spending growth is projected to outpace that of the gross domestic product (GDP) during the coming decade, according to a study published online June 12 in Health Affairs.Jacqueline A. Fiore, Ph.D., from the Centers for Medicare & Medicaid Services in Baltimore, and colleagues projected growth in national health expend |
![]()
HealthDay
12 June at 03.05 PM
Adverse Effects of Medical Treatment Increasing WorldwideThe burden of adverse effects of medical treatment (AEMT) is increasing, with the proportion of all cases accounted for by the increasing rates seen in older adults, according to a study published online June 11 in BMJ Quality & Safety.Liangquan Lin, from the Chinese Academy of Medical Sciences & Peking University Medical Col |
![]()
HealthDay
07 June at 03.33 PM
Isotretinoin Effective for Acne in Those Receiving Gender-Affirming TherapyIsotretinoin is well tolerated and effective for individuals receiving masculinizing gender-affirming hormonal therapy who have acne, according to a study published online May 29 in JAMA Dermatology.James Choe, from Brigham and Women's Hospital in Boston, and colleagues examined clinical outcomes of isotretinoin among transgender and gen |
![]()
HealthDay
06 June at 10.28 PM
CDC Urges Clinicians to Remain on the Lookout for Mpox Virus InfectionsAmong emergency department patients evaluated for an mpox-compatible rash, the prevalence of mpox is 1.5 percent, according to research published in the June 6 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Carl T. Berdahl, M.D., from Cedars-Sinai Medical Center in Los Angeles, and co |
![]()
HealthDay
05 June at 03.28 PM
ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable MelanomaNeoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by adjuvant nivolumab among patients with resectable, macroscopic stage III melanoma, according to a study published online June 2 in the New England Journal of Medicine to coincide with the annual meeting of the American Soc |
![]()
HealthDay
03 June at 09.12 PM
9.6 Percent of Medical Visits Took Place Via Telehealth in 2021In 2021, 9.6 percent of medical visits took place via telehealth, with a higher percentage seen for mental health visits, according to a research letter published online June 4 in the Annals of Internal Medicine.Sandra L. Decker, Ph.D., from the Agency for Healthcare Research and Quality in Rockville, Maryland, and colleagues describe te |
![]()
HealthDay
31 May at 03.46 PM
1.5 Percent Ruxolitinib Cream Safe, Effective for Teens With EczemaLong-term intermittent use of ruxolitinib cream is well tolerated and provides disease control in adolescent patients with atopic dermatitis (AD), according to a study published online May 2 in the American Journal of Clinical Dermatology.Lawrence F. Eichenfield, M.D., from the University of California San Diego, and colleagues asse |
![]()
HealthDay
30 May at 04.04 PM
Bimekizumab Yields Meaningful Response in Hidradenitis SuppurativaBimekizumab is well tolerated and produces clinically meaningful responses in patients with hidradenitis suppurativa, according to a study published online May 22 in The Lancet.Alexa B. Kimball, M.D., from the Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, and colleagues examined the efficacy and safety of b |
MedScape
30 May at 07.18 AM
Most Chronic Wounds Not Managed by Dermatologists"By examining national trends in patient visits and treatment, we may be able to better inform healthcare utilization for cutaneous wounds," Chandy said. |
MedScape
30 May at 06.51 AM
Psoriasis Tied to Increased Risk for MACE Despite Statin UseThe finding "highlights the need for further research into tailored treatments for cardiovascular risk in psoriasis patients," Ana Ormaza Vera said. |
MedScape
29 May at 11.10 PM
Study Addresses Racial/Ethnic Disparities in Psoriasis RxBlack patients with psoriasis had the lowest rate of switching to another biologic therapy compared with other racial and ethnic groups, suggesting possible disparities in treatment patterns. |
![]()
HealthDay
29 May at 09.17 PM
2007 to 2019 Saw Increase in Inflation-Adjusted Health Care SpendingFrom 2007 to 2019, there was an increase in inflation-adjusted health care spending, largely due to increasing contributions to premiums, according to a research letter published online May 28 in JAMA Internal Medicine.Sukruth A. Shashikumar, M.D., from the Beth Israel Deaconess Medical Center in Boston, and colleagues conducted a cro |
MedScape
29 May at 03.36 AM
Dupilumab: Future Treatment for Pediatric Alopecia Areata?Dupilumab will be compared with placebo in a larger multicenter randomized trial of children with alopecia. |
MedScape
29 May at 03.07 AM
Tapinarof Cream Effective For AD, Down to Age 2 YearsResults from two phase 3 trials showed that topical tapinarof, once a day, was effective and safe in patients with atopic dermatitis as young as 2 years old. |
![]()
HealthDay
28 May at 03.08 PM
Parental E-Cigarette Use Linked to Increase in Pediatric Atopic DermatitisParental electronic cigarette use is associated with increased odds of pediatric atopic dermatitis (AD), according to a research letter published online May 22 in JAMA Dermatology.Gun Min Youn, from the Stanford University School of Medicine in California, and colleagues conducted a retrospective cross-sectional analysis of the 2014 to |
MedScape
27 May at 03.26 AM
Parental e-Cigarette Use May Increase AD Risk in ChildrenParental e-cigarette use was associated with an increased risk for pediatric atopic dermatitis in a retrospective, cross-sectional analysis of US population data. |
MedScape
27 May at 02.51 AM
Eczema Risk Increased in Older Adults on AntihypertensivesUse of antihypertensive drugs was associated with a small increase in the rate of eczematous dermatitis diagnoses in older adults, with varying risks with different classes. |
![]()
HealthDay
24 May at 04.06 PM
Antihypertensives Linked to Eczematous Dermatitis in SeniorsAntihypertensive drugs are associated with an increased risk for eczematous dermatitis in older adults, and the effect sizes are largest for diuretics and calcium channel blockers, according to a study published online May 22 in JAMA Dermatology.Morgan Ye, M.P.H., from the University of California in San Francisco, and colleagues examine |
MedScape
24 May at 06.28 AM
Study Reveals Diverse Skin Manifestations in HemochromatosisAn iron profile workup and dermatological findings, such as hyperpigmentation, resistant pruritus, alopecia, and vitiligo, can help diagnose hemochromatosis. |
MedScape
23 May at 06.32 AM
High-Stage cSCC: Outcomes Superior With Mohs vs WLE"Our hope is that these findings provide additional data to support Mohs as the standard of care for primary surgical treatment of high-stage cSCC," the study's lead author said. |
![]()
HealthDay
22 May at 03.50 PM
Global Life Expectancy, Disease Burden Set to Keep ImprovingLife expectancy and age-standardized disease burden are expected to continue improving between 2022 and 2050, according to the Global Burden of Disease (GBD) study, published in the May 18 issue of The Lancet.Stein Emil Vollset, M.D., M.P.H., and colleagues from the GBD 2021 Forecasting Collaborators provide a reference forecast and a |
MedScape
22 May at 11.00 AM
Top Tools for Measuring AD in Clinical Practice RecommendedConsensus was reached during an in-person meeting attended by 34 individuals with diverse backgrounds. |
MedScape
22 May at 04.53 AM
Home Phototherapy for Psoriasis: Optimizing AccessThe ideal candidate "is averse to using systemic agents but whose disease is beyond the point where topical medicines alone will work," Craig A. Elmets, MD, said. |
![]()
HealthDay
21 May at 10.56 PM
Acrochordons May Be Marker for Metabolic Disease in ChildrenIn pediatric patients, acrochordons may be a marker for metabolic disease, according to a study published online April 29 in Pediatric Dermatology.Rachel K. Greene, M.D., from the University of Michigan in Ann Arbor, and colleagues conducted a single-center retrospective cohort study of outpatient dermatology patients between Jan. 1, 20 |
MedScape
20 May at 11.57 PM
Study Finds Radiotherapy for NMSC in Dermatology GrowingThere is persistent growth in eBT/SRT by a small but expanding proportion of general dermatologists. |
![]()
HealthDay
20 May at 03.58 PM
Individuals With BAP1 Have High Rate of Nail AbnormalitiesIndividuals with BRCA1-associated protein (BAP1) have a high rate of nail abnormalities consistent with onychopapillomas, according to a study published online May 17 in JAMA Dermatology to coincide the annual meeting of the Society for Investigative Dermatology, held from May 15 to 18 in Dallas.Alexandra Lebensohn, from the Nat |
MedScape
20 May at 03.03 AM
Chart Review Highlights Unique AD Features in Older PatientsMore research is "needed to elucidate the unique features of elderly AD in pathophysiology and optimal treatments," the study authors wrote. |
MedScape
19 May at 11.07 PM
Study Identifies Several Onychomycosis Risk FactorsTinea pedis, chronic kidney disease, peripheral vascular disease, and type 2 diabetes were associated with an increased risk for onychomycosis in patients with onychodystrophy. |
MedScape
16 May at 09.26 AM
Skin Tags Linked to Metabolic Syndrome in ChildrenAcrochordons (skin tags) in children and adolescents may serve as a marker for metabolic diseases. |
MedScape
16 May at 09.23 AM
Wits of Pediatric Dermatologists Pitted Against ChatGPTOverall, version 4.0 of the AI tool performed better than version 3.5. |
MedScape
16 May at 05.10 AM
Tranexamic Acid Injection Reduces Bleeding After MohsAdverse effects associated with using the antifibrinolytic were rare. |
![]()
HealthDay
15 May at 07.29 PM
Non-Hispanic Black Melanoma Patients Present With Advanced DiseaseNon-Hispanic Black (NHB) melanoma patients have distinct tumor characteristics, presenting with more advanced disease and exhibiting worse outcomes, according to a study published in the May issue of the Journal of Surgical Oncology.Jessica A. Steadman, M.B.B.S., from the Mayo Clinic in Rochester, Minnesota, and colleagues examined fe |
![]()
HealthDay
15 May at 03.45 PM
AACR Delivers Report on Disparities in Cancer ProgressIn its biennial Cancer Disparities Progress Report published today, the American Association for Cancer Research presents the latest statistics on disparities in cancer progress experienced by ethnic-minority groups and other medically underserved populations in the United States.Robert A. Winn, M.D., from the Virginia Commonwealth Un |
MedScape
14 May at 10.13 AM
US Study Delves Into Risk Factors for MelasmaExposure to hormones, hyperpigmenting drugs, and multiparity increased risk for melasma across different racial groups in a US study of a diverse population. |
![]()
HealthDay
13 May at 10.34 PM
Physicians With Disabilities May Experience DepersonalizationPhysicians with disabilities (PWDs) are significantly more likely to experience depersonalization but not emotional exhaustion when compared with their peers without disabilities, according to a research letter published online May 9 in JAMA Network Open.Lisa M. Meeks, Ph.D., from the University of Michigan Medical School in Ann Arb |
![]()
HealthDay
13 May at 03.50 PM
Study Identifies Factors Associated With Hydroxychloroquine RetinopathyFactors associated with an increased risk for hydroxychloroquine retinopathy have been identified and include female sex, older age, and chronic kidney disease stage 3 or greater, according to a study published online May 9 in JAMA Network Open.April M. Jorge, M.D., from Massachusetts General Hospital in Boston, and colleagues identified |
![]()
HealthDay
13 May at 03.46 PM
Coexistence of Psoriatic Arthritis, Atopic Dermatitis May Offer Treatment InsightsPsoriatic arthritis (PsA) and atopic dermatitis (AD) can coexist, and the presence of both conditions may mean special attention should be given to selecting optimal treatment, according to a study published online April 17 in the Journal of Personalized Medicine.Georgiana Strugariu, from "Grigore T. Popa" University of Medicine and Phar |
MedScape
13 May at 09.58 AM
Patient Preferences Drive Treatment Options for Early HSMost ongoing trials of HS treatments are for moderate to severe disease, Dr Jennifer L. Hsiao said. |
MedScape
13 May at 08.59 AM
Reimbursement Rates for Mohs Surgery Lag Behind InflationHealthcare delivery costs are rising, but there has been a lag in the increase in dermatologic procedure reimbursement rates. |
MedScape
13 May at 07.29 AM
Experts Share Practical Tips for Diagnosing Mild HS"Early HS can mimic an intense folliculitis or furuncles that can sometimes be caused by Staphylococcus infections," Sayed said. |
MedScape
13 May at 06.18 AM
Kids With Skin Diseases Face Stigma, Reduced Quality of LifePhysicians' assessment of disease severity and visibility may underestimate the disease's effects on the patient, data suggested. |
![]()
HealthDay
10 May at 12.42 PM
Cyberattack Cripples Major U.S. Health Care NetworkAscension, a major U.S. health care system with 140 hospitals in 19 states, announced late Thursday that a cyberattack has caused disruptions at some of its hospitals."Systems that are currently unavailable include our electronic health records system, MyChart (which enables patients to view their medical records and communicate with their provid |
MedScape
10 May at 06.19 AM
Immunosuppression Risk Factor for Poor cSCC OutcomesIn contrast to earlier findings, immunosuppression was an independent risk factor for disease-specific death and major poor outcomes. |
MedScape
09 May at 08.55 AM
Adalimumab Improves Blood Parameters in Patients With HSTreatment with adalimumab was associated with improvements in common hematologic abnormalities in patients with hidradenitis suppurativa, particularly in responders. |
MedScape
09 May at 08.47 AM
SDM in Pediatric Dermatology: Step Approach RecommendedA pediatric dermatologist proposes a four-step approach to using shared decision-making (SDM) when caring for children and adolescent patients with acne and other skin conditions. |
MedScape
09 May at 06.33 AM
Evidence Accumulating on Viral Cause of Cutaneous GranulomasOf the cases accruing in the United States and elsewhere, most but not all were linked to inborn errors of immunity. |
![]()
HealthDay
08 May at 03.29 PM
Trifarotene Plus Skin Care Beneficial for Acne VulgarisTrifarotene plus skin care is beneficial for patients with moderate acne vulgaris (AV) and acne-induced hyperpigmentation (AIH), according to a study published online April 29 in the International Journal of Dermatology.Andrew Alexis, M.D., M.P.H., from Weill Cornell Medical College in New York City, and colleagues conducted a phase IV |
![]()
HealthDay
08 May at 03.07 PM
Systemic Antibiotics in First Year of Life Tied to Higher Atopic Dermatitis RiskSystemic antibiotic exposure in the first year of life is associated with higher atopic dermatitis (AD) risk in a dose-response fashion, according to a study published online April 24 in the Journal of Allergy and Clinical Immunology.Courtney Hoskinson, from the University of British Columbia in Vancouver, Canada, and colleagues e |
MedScape
08 May at 04.39 AM
IPC Develops Consensus on Generalized Pustular PsoriasisThe IPC's definition and diagnostic criteria for GPP minimized the complexity of clinical considerations to speed treatment of this potentially life-threatening condition. |
MedScape
07 May at 08.28 AM
Many Drugs Linked to Pediatric SJS-TEN, WHO Data ShowAntiepileptic and anti-infectious agents were the most common classes tied to SJS-TEN. |
MedScape
07 May at 05.02 AM
Some Patients More Likely to Get Opioids After Mohs SurgeryCertain minority populations may be at a higher risk of being prescribed opioids post-operatively, which may confer further risks of complications of chronic opioid use. |
MedScape
07 May at 04.19 AM
Rates of Emotional and Physical Stress High in Mohs SurgeonsAlmost three quarters of survey respondents reported experiencing psychological and emotional stress or burnout associated with being a Mohs surgeon and 68% reported a musculoskeletal injury. |
MedScape
06 May at 03.58 AM
Correct Dx of Cancer Treatment Skin Effects EvaluatedThe survey included 81 dermatologists and 182 medical oncologists at six US-based academic institutions. |
MedScape
06 May at 03.35 AM
Review Addresses Skin Manifestations of Cystic FibrosisA review covers the various skin manifestations seen in patients with CF, which include those related to the disease itself, and those associated with treatments for CF. |
MedScape
06 May at 12.01 AM
Many Patients With Advanced MCC Not Receiving ImmunotherapyDespite improved survival rates and guideline recommendations, many eligible patients with metastatic Merkel cell carcinoma are not receiving immunotherapy. |
![]()
HealthDay
02 May at 03.37 PM
Algorithm From EHR Can ID Common Variable Immunodeficiency DiseaseA machine learning algorithm can identify patients with common variable immunodeficiency disease (CVID) from their electronic health records, according to a study published in the May 1 issue of Science Translational Medicine.Due to the low prevalence and extensive heterogeneity in CVID phenotypes, resulting in delayed diagnoses and tre |
MedScape
02 May at 07.17 AM
Mpox Presentation Compared in Racial, Ethnic GroupsA retrospective review that may be the first to examine the topic found differences in mpox symptoms between White non-Hispanic patients and patients of color. |
MedScape
02 May at 07.10 AM
ILD Not Increased With MTX in Patients With DermatomyositisTreatment with methotrexate was not associated with an increased risk for interstitial lung disease (ILD) in patients with dermatomyositis. |
![]()
HealthDay
30 April at 04.12 PM
Stigma Affects Quality of Life in Children With Chronic Skin ConditionsHealth care professionals should consider stigmatization and bullying in assessing the social and mental health of children and adolescents with chronic skin diseases, according to a study published online April 24 in JAMA Dermatology.Amy S. Paller, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and col |
MedScape
30 April at 09.07 AM
Heat-Based Wrinkle Treatment Holds up With Facial AnesthesiaSurface anesthesia prior to thermomechanical fractional injury therapy for wrinkles around the eyes provided adequate comfort, with positive treatment outcomes, a small study found. |
MedScape
30 April at 03.39 AM
Tapinarof Cream for Adult, Pediatric Eczema Under FDA ReviewA decision on approval is expected in the fourth quarter of 2024. |
MedScape
29 April at 05.54 AM
Children With Chronic Skin Disorders Face Substantial StigmaHealthcare professionals should be aware of the possibility of stigmatization and bullying when assessing the social and mental health of children and adolescents with chronic skin disorders. |
MedScape
26 April at 07.49 AM
Prurigo Nodularis Associated With Elevated CV Risks"The potential risk of subsequent cardiovascular disease should be considered in the care of patients with PN," according to the study authors. |
MedScape
25 April at 09.28 AM
FDA Seeks More Information About RDEB Rx Under ReviewPz-cel, which comprises autologous, COL7A1 gene–corrected epidermal sheets, was designed to enable normal type VII collagen expression and facilitate wound healing and pain reduction in RDEB wounds. |
![]()
HealthDay
24 April at 07.53 PM
Tobacco Smoking Reduces the Odds of Psoriasis ImprovementTobacco smoking is negatively associated with resolution of psoriasis symptoms, according to a study published in the April issue of Tobacco Induced Diseases.Yan Qiang, from the School of Medicine at Tongji University in Shanghai, and colleagues explored the influence of smoking on treatment efficacy in patients with psoriasis. The |
MedScape
24 April at 03.16 AM
Erenumab Reduces Flushing and Erythema in RosaceaA calcitonin gene-related peptide inhibitor that is FDA-approved for migraine prevention showed early promise against treatment-resistant redness and flushing of rosacea. |
![]()
HealthDay
23 April at 03.53 PM
Atopic Dermatitis Negatively Impacts Mental HealthAtopic dermatitis (AD) negatively impacts patients’ mental health (MH), especially when a patient has severe AD, according to a study published online March 14 in Dermatitis.Jessica K. Johnson, M.P.H., from the National Eczema Association in San Rafael, California, and colleagues evaluated patient-reported MH symptoms and their c |
MedScape
22 April at 08.32 AM
Hair Loss: Experts Provide Recommendations on Oral MinoxidilThe authors "identified a need for expert-based guidelines for prescribing and monitoring LDOM use in hair loss patients." |
MedScape
22 April at 06.12 AM
Neuromodulators: Rapid-Onset Option, Other Emerging TrendsExpect intradermal injections of botulinum toxin A for the improvement in the appearance of pores, sebum, skin texture, and rosacea to gain a foothold in dermatology practices, one expert says. |
MedScape
22 April at 03.32 AM
Study Shows Faster Recovery, Less Pain With 2910-nm LaserA small study of the 2910-nm erbium-doped fluoride glass fiber laser for facial ablation showed that patients had faster recovery times and less pain than with conventional lasers. |
MedScape
22 April at 03.22 AM
Does AD Severity Affect Growth in Children?An analysis evaluated growth in a study of 1326 children with AD younger than 12 years. |
![]()
HealthDay
19 April at 03.41 PM
Review Explores Cutaneous Manifestations of Myelodysplastic SyndromeCutaneous manifestations of myelodysplastic syndrome (MDS) are described in a perspective piece published in the April issue of Skin Health and Disease.Xiang Li Tan, M.B.B.S., from St. George's University Hospitals NHS Foundation Trust in London, and colleagues conducted a systematic review to examine the prevalence, types, and prognos |
MedScape
19 April at 08.52 AM
Less PIH After Modified Laser Rx for Lentigines ReportedA 532-nm picosecond laser with fractional-beam microlens array to treat solar lentigines resulted in a lower hyperpigmentation rate in patients with darker skin types, vs the full-beam approach. |
MedScape
19 April at 04.58 AM
Registry Gives Snapshot of Cosmetic Procedure-Related AEsA registry of adverse events from dermatologic procedures found that blistering, hypopigmentation, scars, and burns are the most common complications from laser and energy devices. |
MedScape
18 April at 06.44 AM
Laser, Light Treatments Effective for PCOS-Related HirsutismLaser and light hair treatments, with and without other treatments, improve hirsutism and related psychological measures in women with PCOS. |
MedScape
18 April at 02.59 AM
Weekly Laser Treatment Promising for Port-Wine BirthmarksOnce-weekly PDL treatment in infants led to near-total or total clearance of PWB and was well-tolerated in 10 infants, suggesting further investigation of the reduced treatment interval of 1 week. |
![]()
HealthDay
17 April at 04.00 PM
Erenumab Effective, Safe for Rosacea-Linked Erythema, FlushingThe anticalcitonin gene-related peptide-receptor monoclonal antibody erenumab is effective and safe for treatment of rosacea-associated erythema and flushing, according to a study published online April 17 in JAMA Dermatology.Nita K.F. Wienholtz, M.D., Ph.D., from Copenhagen University Hospital-Rigshospitalet in Denmark, and colleag |
MedScape
17 April at 09.37 AM
Study Evaluates Time of Lung Disease Onset With Rare DMRapidly progressive interstitial lung disease was diagnosed in almost half of the patients with MDA5 antibody-positive dermatomyositis. |
MedScape
16 April at 02.08 PM
CDC Investigating Reactions Linked to Counterfeit 'Botox'Reactions have included blurry vision, double vision, drooping eyelids, difficult swallowing or breathing, and other symptoms of botulism. |
![]()
HealthDay
16 April at 11.40 AM
CDC Warns of 19 Cases of Botched Botox Shots in 9 StatesCounterfeit or mishandled Botox shots have triggered harmful reactions in 19 people in nine states, U.S. health officials warned Monday.In its alert, the U.S. Centers for Disease Control and Prevention said nine people had been hospitalized and four we |
MedScape
16 April at 06.17 AM
Survey Highlights Impact of Cosmetic-Procedure ComplicationsStudy finds that people who have complications after cosmetic procedures have higher rates of depression, anxiety, and other mental health issues than before the procedures. |
MedScape
16 April at 06.05 AM
Counterfeit Neurotoxin Investigations Prompt Call for ActionThe American Society for Dermatologic Surgery Association emphasized the risks for medical procedures in unlicensed settings. |
MedScape
16 April at 05.35 AM
Review Evaluates Data on Injectables in Skin of ColorIn this literature review, researchers found that neuromodulators and dermal fillers are useful and safe in SOC populations, although more data are needed in some groups. |
MedScape
15 April at 08.49 AM
Survey Highlights Benefits of Pediatric Derm-Rheum ClinicsPediatric dermatology-rheumatology combined clinics improve patient outcomes and satisfaction. |
MedScape
15 April at 02.03 AM
Review Suggests Skin AEs Rare With PD-1/PD-L1 InhibitorsReports of keratoacanthomas and squamous cell carcinomas associated with the use of PD-1/PD-L1 inhibitors appeared to be relatively rare. |
MedScape
15 April at 01.34 AM
Alopecia Areata: Late Responses to JAK Inhibitors ReportedResponse curves have continued to climb for as long as patients are followed, allowing many with disappointing early results to catch up, according to data presented at the AAD meeting. |
MedScape
12 April at 09.42 AM
Extension Data Reported for Chronic Hand Eczema TreatmentOver 1 year after phase 3 studies suggested that delgocitinib cream was safe and effective for chronic hand eczema, extension data indicate that control persists without new safety issues. |
MedScape
12 April at 08.58 AM
Topical Vs Oral Minoxidil for AGA: Which Is More Effective?Efficacy and safety of the two formulations were directly compared in a randomized, controlled, double-blind study of men with AGA conducted in Brazil. |
MedScape
12 April at 08.25 AM
What's Behind Long-Term Antibiotic Prescribing for Acne?"This study explored why dermatologists still prescribe a good number of long-term antibiotics for people with acne," the study's senior author Howa Yeung, MD, MSc, said in an interview. |
![]()
HealthDay
10 April at 06.15 PM
Study Identifies Factors That Affect Antibiotic Prescribing for AcneMultiple salient factors affect long-term antibiotic prescribing practices for acne, according to a study published online April 3 in JAMA Dermatology.Ronnie A. Festok, from the Emory University School of Medicine in Atlanta, and colleagues conducted a qualitative study assessing data collected from stakeholders (dermatologists, inf |
![]()
HealthDay
10 April at 03.57 PM
Bioactive Retinol Efficacious for Improving Signs of PhotoagingStabilized bioactive retinol is efficacious for improving signs of photoaging, without causing major irritation, according to a study published in the April issue of the Journal of Drugs in Dermatology.Patricia Farris, M.D., from Tulane University School of Medicine in New Orleans, and colleagues examined the comprehensive efficacy |
MedScape
10 April at 07.46 AM
New Tool Could Help Screen Patients for Zoom DysmorphiaIndividuals with zoom dysmorphia tend to scrutinize their facial features and fixate on what they think needs to improve and feel pressured to appear perfect before virtual meetings. |
MedScape
10 April at 05.22 AM
Childhood Atopic Dermatitis Linked to IBD RiskA prospective Swedish study reported that childhood atopic dermatitis is linked to an increased risk for inflammatory bowel disease. |
MedScape
09 April at 03.18 AM
Expert Recommends Phased Approach For Delusional InfestationPhase 4 involves initiating therapy, which includes demonstrating empathy by reflecting on the detrimental effects of the patient's reported sensations on their quality of life. |
MedScape
09 April at 12.35 AM
Hidradenitis Suppurativa: Sonelokimab Shows Promise in StudySonelokimab is a novel humanized nanobody that selectively binds to interleukin (IL)-17A and IL-17F. |
![]()
HealthDay
08 April at 10.30 PM
FDA Approves New Antibiotic for Three IndicationsThe U.S. Food and Drug Administration has approved the antibiotic Zevtera (ceftobiprole medocaril sodium for injection) for three different indications, including treatment of adults with Staphylococcus aureus bloodstream infections, adults with acute bacterial skin and skin structure infections, and adult and pediatric patients (age 3 months |
MedScape
05 April at 08.16 AM
Transplant Recipients: Consider Skin Cancer, Infection RisksRecent research sheds light on varying skin cancer risk, and a predictive tool offers guidance on screening in solid organ transplant recipients. |
MedScape
05 April at 03.22 AM
Medicare IHC Claims With Melanoma Dxs Increased, Study FindsWith sparse guidance regarding best practices for IHC in melanoma diagnosis, more research is needed to optimize use of IHC in this setting, according to the authors. |
MedScape
05 April at 02.17 AM
FDA Accepts Application for a New HS TreatmentBimekizumab is currently approved in the United States for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. |
MedScape
04 April at 06.39 AM
Review Describes Semaglutide-Associated Skin EffectsAlopecia, dysesthesia, and other types of skin sensations have been reported in patients treated with semaglutide, but more research is needed to understand skin findings associated with this drug. |
![]()
HealthDay
03 April at 03.45 PM
Second Primary Malignancy Risk Increased After Cutaneous B-Cell LymphomaPatients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a study published online March 19 in the Journal of the American Academy of Dermatology.Lauren Banner, from Thomas Jefferson University in Philadelphia, and colleagues used the Surveillance, Epidemiolo |
MedScape
03 April at 06.01 AM
Rilzabrutinib Plus Low-Dose Steroid Fails Pemphigus TrialRilzabrutinib did not meet primary or secondary endpoints in the phase 3 PEGASUS trial of patients with pemphigus vulgaris or foliaceus. |
MedScape
03 April at 03.29 AM
Ruxolitinib Cream Shows Promise for Hidradenitis SuppurativaTreatment with the topical JAK inhibitor reduced abscess and inflammatory nodules in a phase 2 randomized, controlled trial in patients with mild hidradenitis suppurativa. |
MedScape
03 April at 02.33 AM
Intralesional Wart Treatments Are Among Options to ConsiderAlternatives to SA and cryotherapy for warts may be helpful "for patients who have failed traditional therapies or have a contraindication to the usual go-tos," said Dr Jennifer Adams. |
MedScape
02 April at 07.41 AM
JAK Inhibitors for Vitiligo: More Skin Response Over TimeTwo JAK inhibitors for non-segmental vitiligo showed better skin clearance in phase 2b trial extensions — ritlecitinib plus twice-weekly doses of UVB light and upadacitinib. |
MedScape
01 April at 01.39 AM
Tooth Enamel Disorder Is a Feature of Kindler EBStudy found that hypoplastic pitted amelogenesis imperfecta is among the oral manifestations of Kindler epidermolysis bullosa, underscoring the need for early and sustained dental care. |
MedScape
01 April at 01.16 AM
Rate of Malignancy Low in Pediatric LMPediatric longitudinal melanonychia may look like subungual melanoma in adults, but a low probability of malignancy makes clinical monitoring a reasonable noninvasive management strategy. |
![]()
HealthDay
29 March at 03.14 PM
U.S. Doctors Received Industry Payments of $12.13 Billion From 2013 to 2022U.S. physicians received $12.13 billion from industry from 2013 to 2022, according to a research letter published online March 28 in the Journal of the American Medical Association.Ahmed Sayed, M.B.B.S., from Ain Shams University in Cairo, and colleagues examined the distribution of payments within and across specialties and the medica |
![]()
HealthDay
29 March at 11.42 AM
High-Strength Lidocaine Skin Creams Can Cause Seizures, Heart Trouble, FDA WarnsSome pain-relieving skin products contain potentially harmful doses of the numbing agent lidocaine and should be avoided, the U.S. Food and Drug Administration warns.These creams, gels, sprays and soaps are marketed for topical use to relieve the pain of cosmetic procedures like microdermabrasion, laser hair removal, tattooing and <a href="http |
MedScape
27 March at 12.24 PM
FDA Warns Consumers Against Using Some Topical AnalgesicsThe warning applies to unapproved products illegally marketed for topical use to relieve pain before, during, or after cosmetic procedures. |
MedScape
26 March at 06.37 AM
Hair-Straightening Products Entail Acute Kidney Failure RiskProducts containing glyoxylic acid were associated with the accumulation of calcium oxalate crystals in the kidneys. |
![]()
HealthDay
25 March at 03.55 PM
Social Media + Photo-Editing Apps Tied to Higher Interest in Cosmetic ProceduresTime spent on social media and use of photo-editing applications contribute to the desire to undergo a cosmetic procedure, according to a study recently published in the Journal of Clinical and Aesthetic Dermatology.Iman F. Khan, M.D., M.P.H., from Boston University, and colleagues surveyed 175 adults visiting an outpatient dermat |
![]()
HealthDay
22 March at 10.09 PM
Four in 10 Adults Choose Telemedicine VisitsMany patients, including those with the greatest care needs, choose telemedicine even when in-person visits are available, according to a study published online March 22 in JAMA Network Open.Eva Chang, Ph.D., M.P.H., from Advocate Health in Milwaukee, Wisconsin, and colleagues assessed patient characteristics associated with telem |
![]()
HealthDay
22 March at 03.58 PM
Survey Assesses Perspectives on Patient Image Use in DermatologyMost patients report an increase in trust in the quality of their medical care if asked for permission to use their images for research or education, according to a research letter published online March 13 in JAMA Dermatology.Trina Salvador, from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues conducted a s |
![]()
HealthDay
22 March at 03.56 PM
Physicians Concerned About Private Equity's Impact on Health CarePhysicians express largely negative views about the impact of private equity (PE) on the health care system, according to a research letter published online March 11 in JAMA Internal Medicine.Jane M. Zhu, M.D., from Oregon Health and Science University in Portland, and colleagues conducted a survey to assess physicians' views towa |
MedScape
22 March at 01.58 AM
Acne Products With Benzoyl Peroxide Under ScrutinyIn a citizen's petition, Valisure asked the FDA to recall acne products with benzoyl peroxide, stirring debate. |
![]()
HealthDay
21 March at 10.59 PM
Life Expectancy Increased From 2021 to Reach 77.5 Years in 2022Life expectancy increased to 77.5 years in 2022, while the age-adjusted rate of drug overdose deaths increased from 2002 to 2022 but did not change from 2021 to 2022, according to two March data briefs published by the National Center for Health Statistics.Kenneth D. Kochanek, from the National Center for Health Statistics in Hyattsville, Mar |
MedScape
21 March at 09.16 AM
AI in Dermatology: Consider Its Limitations and ProblemsArtificial intelligence is coming to clinical dermatology, but its enormous promise for improving the lives of patients and physicians will depend on addressing the expected problems. |
MedScape
21 March at 07.58 AM
Immunomodulators Do Not Affect COVID-19 Vaccine EfficacyA study suggested that immunomodulatory medications do not increase the risk for COVID-19 related hospitalizations in patients who have received the COVID-19 vaccine. |
MedScape
20 March at 01.03 PM
Study Evaluates Acne Risk With Reversible ContraceptionIn the study, 28.5% of the adolescents and young adults experienced worsening acne after insertion of a progestin-only long-acting reversible contraceptive, and 17% reported acne as a new concern. |
MedScape
20 March at 07.14 AM
FDA Expands Approval of Treatment for GPPSpesolimab-sbzo was initially approved in 2022 for treating flares of generalized pustular psoriasis in adults. |
![]()
HealthDay
19 March at 11.05 PM
American Academy of Dermatology, March 8 to 12The annual meeting of the American Academy of Dermatology was held from March 8 to 12 in San Diego and attracted participants from around the world, including clinicians, academicians, allied health professionals, and others interested in dermatology. The conference highlighted recent advances in the diagnosis and management of d |
![]()
HealthDay
19 March at 03.42 PM
AAD: Continuous Improvements Seen Through 68 Weeks for Deuruxolitinib in AlopeciaFor adults with alopecia areata, continuous improvements are seen through 68 weeks with deuruxolitinib, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 12 in San Diego.Brett King, M.D., Ph.D., from the Yale School of Medicine in New Haven, Connecticut, and colleagues reported po |
MedScape
19 March at 07.48 AM
Roflumilast Cream Quickly Improved AD in Children, Ages 2-5Among patients treated with roflumilast cream, 0.05%, 25.4% reached the primary endpoint of "clear" or "almost clear" plus a two-grade improvement from baseline at week 4. |
![]()
HealthDay
18 March at 03.55 PM
AAD: Lebrikizumab Shows Efficacy in Skin-of-Color Patients With Atopic DermatitisLebrikizumab demonstrates improvement in skin clearance and itch relief in patients with skin of color and moderate-to-severe atopic dermatitis, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 12 in San Diego.Andrew Alexis, M.D., M.P.H., from Weill Cornell Medicine in New York Ci |
![]()
HealthDay
18 March at 03.52 PM
AAD: Hair Regrowth Continues to Improve at 76 Weeks With Baricitinib for Severe AlopeciaMONDAY, March 18, 2024 (HealthDay News) -- Continuous treatment with baricitinib in patients with severe alopecia areata demonstrates improvement in hair regrowth outcomes through 76 weeks of follow-up, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 12 in San Diego.Rodney D. Sinclair, M.D., from the University of Me |
MedScape
18 March at 05.46 AM
Tips on Managing Acne in Transmasculine PatientsTestosterone therapy can exacerbate symptoms, and other factors are important to consider, expert said. |
![]()
HealthDay
15 March at 03.25 PM
AAD: Adult Acne Clinic Visits Increase With Exposure to Wildfire-Related Air PollutionShort-term exposure to wildfire-related air pollution is associated with an increase in clinic visits for acne vulgaris among adults, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 10 in San Diego.Alex Ha, from the University of California, San Francisco, and colleagues conducte |
![]()
HealthDay
15 March at 03.21 PM
AAD: Bimekizumab Response Durable at Four Years for Moderate-to-Severe PsoriasisFRIDAY, March 15, 2024 (HealthDay News) -- Patients with psoriasis treated with bimekizumab rapidly achieve high levels of clinical and health-related quality-of-life responses that are durable at four years, according to research presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 10 in San Diego.Bruce Strober, M.D., Ph.D., from the Yale Sc |
MedScape
15 March at 11.40 AM
Prurigo Nodularis: Nemolizumab Efficacy Persists at 52 WeeksThe encouraging long-term efficacy and safety associated with nemolizumab (IL-31 inhibitor) in prurigo nodularis was supported by a second set of data showing long-term benefit in atopic dermatitis. |
MedScape
15 March at 05.49 AM
Most Baby Cleansers Are Not 'Allergen-Free,' Study FindsA recent study demonstrated that 94% of top-selling baby cleansers contain allergens, despite having hypoallergenic claims. |
![]()
HealthDay
14 March at 12.04 PM
HHS Opens Investigation Into UnitedHealth CyberattackFollowing a cyberattack on one of the nation's largest health insurers that's thrown health care payments into disarray and likely exposed reams of private patient data, the U.S. Department of Health and Human Services said Wednesday it has begun an investigation into the incident.In a <a href="https://www.hhs.gov/about/news/2024/03/13/h |
MedScape
14 March at 09.07 AM
Major Responses Seen for Cicatricial and Total Hair LossTwo oral therapies targeted at kinase pathways produced meaningful responses in patients with severe types of alopecia in late-breaking studies at the American Academy of Dermatology. |
MedScape
14 March at 06.42 AM
Florida Bill Addresses Coverage of Skin Cancer ScreeningSome 321,000 state employees would be eligible, at a cost of about $357,000 per year, according to one analysis. |
![]()
HealthDay
13 March at 12.05 PM
Cyberattack Leaves Health Care Providers Reeling Weeks LaterFollowing a cyberattack on the largest health insurer in the United States last month, health care providers continue to scramble as insurance payments and prescription orders continue to be disrupted and physicians lose an estimated $100 million a day.That <a href="https://www.ama-assn.org/press-center/press-releases/cyberattack-jeopardizes |
MedScape
13 March at 07.06 AM
2024 AAD Acne Guidelines: Newer Therapies Join Old StandbysA coauthor of the new recommendations highlights updated advice and comments on worrisome benzene news. |
![]()
HealthDay
12 March at 10.49 PM
Atopic Dermatitis in Children Tied to Learning, Memory DifficultiesPediatric atopic dermatitis (AD) is associated with greater odds of reported difficulties in learning and memory, but this association is driven by children with neurodevelopmental comorbidities, according to a study published online March 6 in JAMA Dermatology.Emily Z. Ma, from the University of Maryland School of Medicine |
MedScape
12 March at 04.54 PM
Lebrikizumab Found Effective for Patients With AD, SOCInterim results at 16 weeks were based on 50 adolescents and adults with skin types IV-VI. |
MedScape
11 March at 05.36 PM
Study Eyes Effect of Maternal HS on Outcomes in OffspringThe study population included nearly 1.3 million children born in Quebec, Canada, over a 16-year period. |
MedScape
10 March at 07.53 PM
Anti-IL-17, Anti-IL-23 Rxs Show Sustained Psoriasis ControlBoth an approved anti-IL-17 therapy and an experimental oral anti-IL-23 therapy appeared to achieve relatively undiminished rates of psoriasis control in extension studies. |
MedScape
10 March at 05.01 PM
Home- and Office-Based Phototherapy for Psoriasis ComparedThe multicenter LITE trial included 783 patients at 42 sites in the United States. |
MedScape
10 March at 02.29 PM
During Pregnancy, Many Drugs Safe for Skin InfectionsSeveral drugs should be avoided or used with caution because of potential risks during pregnancy, a dermatologist told colleagues. |
MedScape
09 March at 04.07 PM
New NCCN Melanoma Guidelines Capture Evolving Best PracticeNCCN guidelines for cutaneous melanoma, issued in February, capture evolving data for both diagnosis and treatment, diverging incrementally from 2019 AAD guidelines. |
MedScape
09 March at 02.41 PM
Novel Drug Shows Promise for Hidradenitis SuppurativaThe findings suggest that Bruton's tyrosine kinase inhibition may emerge as a promising therapeutic intervention in HS. |
MedScape
08 March at 06.28 PM
Flexibility Advised for Patients With Personality DisordersUp to 15% of the general population is affected by a personality disorder, according to dermatologist, Mio Nakamura, MD. |
![]()
HealthDay
08 March at 04.59 PM
AAD: Concerns Noted Relating to Use of AI Dermatology AppsThere are notable concerns relating to the use of currently available artificial intelligence (AI) dermatology mobile applications (apps), according to a study published online March 7 in JAMA Dermatology to coincide with the annual meeting of the American Academy of Dermatology, held from March 8 to 10 in San Diego.Shannon Wongvibulsin |
MedScape
08 March at 04.07 PM
Anti-DEI Petition Sparks Conflict at Nat'l Derm MeetingA controversial proposal to end the American Academy of Dermatology diversity programs will be considered at the group's annual meeting starting today. |
MedScape
08 March at 08.01 AM
Sulfites Selected as ACDS Allergen of the YearExperts lobby for increased inclusion of sulfites in patch test panels. |
MedScape
08 March at 06.14 AM
Psoriasis Study Shows a Path for Considering US Drug CostsOnly three of 13 psoriasis biologics appeared to be cost-effective based on US prices in a new analysis. The finding may aid policymakers struggling with drug price negotiations. |
![]()
HealthDay
07 March at 02.00 PM
Carcinogen Benzene Can Form in Some Acne Treatments: ReportSome acne treatments may banish blemishes but carry hidden dangers: A new report reveals high levels of the carcinogen benzene can form in products that contain the zit-fighting ingredient benzoyl peroxide.According to the new report from |
MedScape
07 March at 07.06 AM
Is Atopic Dermatitis Linked to Cognitive Impairment Symptoms in Children?The analysis included children aged 17 years or younger without intellectual disability or autism. |
![]()
HealthDay
06 March at 04.38 PM
Skin of Color Underrepresented in AI Programs in DermatologyChallenges relating to artificial intelligence (AI) in dermatology and its application to skin of color (SOC) are partly due to underrepresentation of SOC in datasets, according to research published online March 6 in the International Journal of Dermatology.Rebecca Fliorent, from the Rowan-Virtua School of Osteopathic Medicine in St |
MedScape
06 March at 01.53 AM
New Indication Approved for JuvédermIn a randomized, controlled trial, 59% of adults reported experiencing at least one treatment site response. |
![]()
HealthDay
06 March at 12.00 AM
Tacrolimus Microemulsion Has Good Efficacy, Safety for Scalp PsoriasisFor scalp psoriasis, 0.1 percent tacrolimus microemulsion has good efficacy and safety, according to a study published online Feb. 12 in Dermatology and Therapy.Andreas Pinter, M.D., from the University Hospital Frankfurt in Germany, and colleagues conducted a multicenter, double-blind, vehicle-controlled phase 3 trial to examine the e |
![]()
HealthDay
06 March at 12.00 AM
Higher Use of Health Care Portal Seen During COVID-19 PandemicHealth care portal use was higher during the COVID-19 pandemic, according to a study published online Feb. 29 in JAMA Network Open.Esther Yoon, Ph.D., M.P.H., from the Feinberg School of Medicine at Northwestern University in Chicago, and colleagues examined the prevalence of health care portal use before, during, and after the most re |
MedScape
04 March at 10.21 PM
FDA Approves Another Neurotoxin for Frown LinesThe product has been sold in more than 50 countries, the company says. |
MedScape
03 March at 11.01 PM
Patient-Reported Outcomes Important in Cutaneous GVHD: StudyThe study results "highlight the importance of patient-reported outcomes in measuring this disease," the study's lead author said. |
MedScape
01 March at 02.06 AM
Review Highlights Evidence of Climate Change Effects on ADAtopic dermatitis "could serve as a case study for climatic impacts on health," the authors emphasized in their paper. |
MedScape
29 February at 11.18 PM
Study Finds No Increased Cancer Risk With SpironolactoneOver 5 years, treatment with spironolactone for dermatologic conditions was not associated with a greater risk for breast or gynecologic cancers, when compared with women not using spironolactone. |
MedScape
29 February at 12.45 AM
What’s The Incidence Rate of a Second Primary Melanoma?The findings may have potential implications for more personalized surveillance of patients with melanoma, the authors said. |
![]()
HealthDay
27 February at 04.59 PM
Delayed Melanoma Care During Pandemic Proved CostlyDelays in melanoma diagnoses due to COVID-19 pandemic lockdowns were associated with a significant burden, including years of life lost and costs, according to a study published online Feb. 16 in JAMA Network Open.Lara V. Maul, M.D., from University Hospital of Basel in Switzerland, and colleagues examined the consequences associa |
MedScape
27 February at 07.38 AM
What Drives Fatigue in Psoriasis and PsA?Joint pain and itch were key culprits, according to a cross-sectional analysis of Danish data. |
![]()
HealthDay
26 February at 05.02 PM
Observed Rates of Cancer Diagnoses Lower Than Expected in PandemicDuring the COVID-19 pandemic, cancer diagnoses were lower than expected, according to a study published online Feb. 22 in JAMA Oncology.Todd Burus, from the Markey Cancer Center at the University of Kentucky in Lexington, and colleagues conducted a population-based cross-sectional analysis of cancer incidence trends using data on cases |
MedScape
26 February at 01.47 AM
TikTok Info on Infantile Hemangiomas Suspect: StudyIn a cross-sectional study of the social media platform, researchers analyzed 50 videos on the topic. |
MedScape
26 February at 12.34 AM
Biologic Treatment for Psoriasis Linked to Lower MortalityEvidence to support the hypothesis that the use of systemic immunomodulatory agents for psoriasis "quenches systemic inflammation and potentially improves" survival is limited, investigators said. |
![]()
HealthDay
23 February at 11.30 PM
Level of Burnout Higher for Women in Health Care OccupationsWomen in health care occupations endure a significantly higher level of stress and burnout than men, according to a study published online Feb. 21 in Global Advances in Integrative Medicine and Health.Viktoriya Karakcheyeva, M.D., from the George Washington University School of Medicine and Health Sciences in Washington, D.C., and colle |
MedScape
23 February at 12.38 PM
EMA Approves Tx for Psoriasis and Other Autoimmune DisordersThe biosimilar Pyzchiva is highly similar to Stelara, which was approved in the EU in 2009. |
MedScape
23 February at 09.00 AM
'Superclinic' Powers Through Skin Cancer ReferralsOne hospital's experience with this model shows the efficiency of using a dedicated team (including trainees) and offering same-day biopsies and surgery. |
MedScape
23 February at 01.34 AM
Longer IV Ertapenem Course Beneficial for Recalcitrant HS2019 treatment guidelines published recommended ertapenem as a highly effective third-line therapy limited to a shorter course, as rescue therapy or during surgical planning. |
![]()
HealthDay
22 February at 12.17 PM
Jill Biden Announces $100 Million for Research on Women's HealthFirst Lady Jill Biden on Wednesday announced $100 million in federal funding to fuel research into women's health.“We will build a health care system that puts women and their lived experiences at its center,” Biden said in a White House <a href="https://www.whitehouse.gov/briefing-room/speeches-remarks/2024/02/21/remarks-as-prepared-for-deliv |
MedScape
22 February at 08.13 AM
One-a-Day Pill for Alopecia Recommended for NHS UseNICE said there is unequal treatment for people with severe alopecia areata across England and Wales and its approval of ritlecitinib could benefit up to 14,000 people. |
![]()
HealthDay
21 February at 04.01 PM
Clinical Markers Improve With IV Ertapenem for Hidradenitis SuppurativaTreatment of hidradenitis suppurativa (HS) with intravenous ertapenem is associated with improvement in clinical and inflammatory markers, according to a study published online Feb. 19 in JAMA Dermatology.Avigdor Nosrati, M.D., from the Albert Einstein College of Medicine in New York City, and colleagues conducted a retrospective rev |
![]()
HealthDay
21 February at 01.45 PM
This Election Year, Health Care Costs Top Voter Concerns: PollUnexpected medical bills and high health care costs are dominating an election where kitchen table economic problems weigh heavily on voter’s minds, a new KFF poll has found.Voters struggling to pay their monthly bills are most eager to hear presidential candidates talk about economic and health care issues, according to the latest KFF Health |
MedScape
21 February at 02.12 AM
Nemolizumab Being Reviewed for AD, Prurigo NodularisFor prurigo nodularis, the FDA has granted nemolizumab, a monoclonal antibody designed to inhibit interleukin-31 signaling, priority review. |
MedScape
20 February at 10.49 PM
What Skin Manifestations Are Associated With Pediatric IBD?Skin conditions both specific and nonspecific to IBD are prevalent in children and adolescents with IBD, with infectious conditions being the most common. |
![]()
HealthDay
20 February at 04.26 PM
Amtagvi Approved by the FDA for Treatment of Advanced MelanomaAmtagvi (lifileucel) has been approved by the U.S. Food and Drug Administration for the treatment of advanced melanoma. Amtagvi becomes the first cellular therapy approved to treat this form of solid tumor cancer."The approval of Amtagvi offers hope to those with advanced melanoma who have progressed following initial standard-of-care therapies |
![]()
HealthDay
17 February at 12.00 AM
Expanded Use of Xolair to Treat Food Allergies Approved by the FDAThe U.S. Food and Drug Administration has expanded the use of the asthma drug Xolair (omalizumab) to help prevent anaphylactic reactions.Xolair is an injected drug and is not meant as a substitute for EpiPens or other anaphylaxis rescue remedies, the agency stressed. Instead, "Xolair is intended for repeated use to reduce the risk of allergic re |
![]()
HealthDay
16 February at 04.32 PM
Deep Learning Improves Diagnostic Accuracy for Skin DiseasesDeep learning-aided decision support improves diagnostic accuracy for skin disease, according to a study published online Feb. 5 in Nature Medicine.Matthew Groh, Ph.D., from the Northwestern University Kellogg School of Management in Evanston, Illinois, and colleagues presented results from a study involving 389 board-certified dermatol |
MedScape
16 February at 12.53 AM
Cellulite: Outcomes 1 Year After Noninvasive TreatmentThe findings build on results from a 12-week study of the device, which the investigators said "induces physical shearing of fibrous septa through rapid acoustic pulses." |
MedScape
16 February at 12.02 AM
Tapinarof Under FDA Review for Treating Atopic DermatitisApproved in 2022 for psoriasis, the manufacturer has submitted an application for approval of tapinarof cream for treating atopic dermatitis in adults and children 2 years of age and older. |
![]()
HealthDay
15 February at 04.42 PM
FDA Approves Aurlumyn for Severe FrostbiteAurlumyn (iloprost), a vasodilator, has been approved by the U.S. Food and Drug Administration to treat severe frostbite. The injected medication lowers the risk for finger or toe amputation."This approval provides patients with the first-ever treatment option for severe frostbite," Norman Stockbridge, M.D., director of the Division of Cardiol |
![]()
HealthDay
14 February at 11.06 PM
Study Looks at Access to U.S. Burn Centers Using 2019 DataAccess disparities to burn centers persist, with lower access in the South and West and for those with lower income, according to a research letter published online Feb. 14 in JAMA Surgery.Dong Gi Hur, from the Stanford School of Medicine in California, and colleagues characterized access to American Burn Association (ABA)-verified a |
MedScape
14 February at 02.14 AM
Lab Testing in Patients on Immunomodulators Falls ShortReview found that fewer than 60% of patients with chronic inflammatory skin diseases underwent recommended testing before starting systemic immunomodulator treatment. |
MedScape
13 February at 11.11 PM
Tinea Capitis Management in Kids Varies, Survey FindsRespondents included 56 members of the Pediatric Dermatology Research Alliance. |
![]()
HealthDay
12 February at 04.17 PM
Link Between Inflammatory Disease, Adverse Pregnancy Outcomes VariesThe association between immune-mediated inflammatory diseases (IMIDs) and adverse pregnancy outcomes varies with the nature of IMID and the presence of comorbidities, according to a study published online Feb. 1 in eClinicalMedicine.Yeon Mi Hwang, from the Institute for Systems Biology in Seattle, and colleagues conducted a retrospectiv |
![]()
HealthDay
12 February at 04.13 PM
Smoking Linked to Melanoma-Associated Death in Early-Stage MelanomaFor patients with clinical stage I and II melanoma, smoking is associated with an increased risk for melanoma-associated death, according to a study published online Feb. 6 in JAMA Network Open.Katherine M. Jackson, M.D., from the Saint John's Cancer Institute at Providence Saint John's Health Center in Santa Monica, California, and col |
MedScape
09 February at 05.04 PM
Tools on the Horizon for Managing Posttransplant cSCC RiskOrgan transplant recipients have a 200-fold increased incidence of keratinocyte carcinoma compared with immunocompetent individuals, and cSCC accounts for 80% of skin cancers in those recipients. |
![]()
HealthDay
09 February at 04.56 PM
Health Care Costs, Resource Utilization Increased for Vitiligo PatientsPatients with vitiligo have significantly higher health care costs and health care resource utilization (HCRU), according to a study recently published in the Journal of Investigative Dermatology.Khaled Ezzedine, M.D., from Henri Mondor University Hospital in Créteil, France, and colleagues conducted a retrospective cohort analysis |
MedScape
09 February at 04.42 PM
Analysis Finds Allergens in Many Topical Scar ProductsOf the 156 products identified, most were gels, creams, or oils. |
MedScape
09 February at 05.44 AM
Spitz Nevi: An Expert Shares Tips for Diagnosis, ManagementDr Caroline Piggott provides her perspective on dermoscopy, shave vs punch biopsies, and treatment. |
MedScape
09 February at 02.26 AM
Periocular Melanoma Still Rare, But May Be IncreasingPain and vision loss are late symptoms of periocular melanoma, and there are amelanotic variants. |
MedScape
09 February at 12.38 AM
Study Shows Disparities in Diagnosing Across Skin TonesAcross all images, diseases in darker skin types were diagnosed less accurately than diseases in lighter skin types, including when decision support from a deep learning system was introduced. |
![]()
HealthDay
08 February at 04.39 PM
JNJ-77242113 Shows Greater Efficacy Than Placebo for Plaque PsoriasisFor patients with moderate-to-severe plaque psoriasis, the interleukin-23-receptor antagonist peptide JNJ-77242113 shows greater efficacy than placebo, according to a study published in the Feb. 8 issue of the New England Journal of Medicine.Robert Bissonnette, M.D., from Innovaderm Research in Montreal, and colleagues conducted a phas |
MedScape
07 February at 11.18 PM
Lifetime Cost of DEB Gene Therapy Could Be $15-$22 MillionThe most expensive gene therapy on the US market may give payers pause, said study authors. |
MedScape
07 February at 05.09 PM
Oral IL-23 Inhibitor Calms Moderate to Severe PsoriasisThe small-molecule oral investigational agent JNJ-77242113 at the highest dose tested was associated with reductions in psoriasis severity comparable to injectable biologic agents. |
MedScape
07 February at 06.09 AM
AAD Updates Acne Management GuidelinesThe new guidelines updated the AAD's 2016 guidelines and included 18 recommendations and five good practice statements. |
MedScape
06 February at 01.46 AM
Dupilumab Improves AD Affecting the Hands, FeetDupilumab monotherapy was an effective and safe systemic treatment for patients with moderate to severe hand and foot atopic dermatitis. |
MedScape
06 February at 01.37 AM
MACE, VTE Risks Not Increased With JAK inhibitors: StudyIn studies with an average follow-up of 16 weeks, there was no significant increase in MACE or VTE rates in people with dermatoses treated with JAK-STAT inhibitors. |
![]()
HealthDay
05 February at 11.45 PM
Price of Prescription Drugs Almost Threefold Higher in the United StatesPrescription drug prices are nearly three times higher in the United States than in other countries, according to a report published by the RAND Corporation.Andrew W. Mulcahy, and colleagues from the RAND Corporation, compared the prices of different categories of drug products, including brand-name originator drugs, unbranded generic drugs, biol |
![]()
HealthDay
05 February at 04.29 PM
AAD Updates Guidelines for Management of Acne VulgarisIn guidelines issued by the American Academy of Dermatology and published online Jan. 30 in the Journal of the American Academy of Dermatology, updated recommendations are presented for the management of acne vulgaris.Rachel V. Reynolds, M.D., from Beth Israel Deaconess Medical Center in Boston, and colleagues conducted a systematic revi |
![]()
HealthDay
02 February at 03.50 PM
Gender Minority Adults Are Vulnerable During Full Body Skin ExamWithin the sexual and gender minority (SGM) population, gender minority adults are more likely to report discomfort during full body skin examinations (FBSEs), according to a research letter published online Jan. 31 in JAMA Dermatology.Michelle Verghese, from the Pritzker School of Medicine at the University of Chicago, and colleagues us |
MedScape
01 February at 02.06 AM
Rosacea and Recent Research Back Potential New TherapiesWhat do botulinum toxin, paroxetine, and a low-molecular-weight heparan sulfate analog have in common? Each has evidence as a potential treatment for people with rosacea. |
MedScape
31 January at 11.32 PM
Successful Acne Scar Treatment Can Boost Quality of LifeThe three main types of acne scars can dictate the approach to treatment. |
![]()
HealthDay
29 January at 10.54 PM
Practitioner Empathy Interventions Can Improve Patient SatisfactionHealth care practitioner empathy interventions seem to improve patient satisfaction, but inadequate reporting hinders the ability to draw definitive conclusions relating to the overall effect size, according to a review published online Jan. 30 in the Annals of Internal Medicine.Leila Keshtkar, Ph.D., from the University of Leicester in |
![]()
HealthDay
29 January at 04.10 PM
Early FDG PET/CT Can ID Metabolic Changes in Advanced MelanomaFor patients with advanced melanoma, early 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) imaging can identify metabolic changes that may predict response to pembrolizumab, according to a study published online Jan. 24 in Clinical Cancer Research.Thomas M. Anderson, M.D., from the Per |
![]()
HealthDay
25 January at 10.58 PM
2004 to 2019 Saw Increase in Isotretinoin Use in Girls, WomenFrom 2004 to 2019, there was an increase in isotretinoin use among girls and women of childbearing age in Germany, according to a study published online Jan. 25 in PLOS Medicine.Jonas Reinold, from the Leibniz Institute for Prevention Research and Epidemiology–BIPS in Bremen, Germany, and colleagues determined the age-standardized pre |
MedScape
25 January at 10.59 AM
Think Outside the Traditional Toolbox to Treat ItchNaloxone and strontium are just a few of the "out of the box" therapies dermatologists can consider for treating chronic itch. |
MedScape
25 January at 06.42 AM
Emerging Therapies Foretell New Era for Cutaneous DisordersAnalogous to the early 2000s when treatment options for psoriasis jumped, the same may be true now for treating cutaneous autoimmune disorders. |
![]()
HealthDay
24 January at 04.55 PM
Climatic Hazards Linked to Aggravation of Atopic DermatitisClimatic hazards are likely to aggravate atopic dermatitis (AD), with the impact including direct and indirect effects, according to a review published online Jan. 24 in Allergy.Sheng-Pei Wang, M.D., M.P.H., from the University of California San Francisco, and colleagues identified 18 studies with evidence for an impact of AD by leve |
MedScape
24 January at 11.00 AM
How Does Rituximab for Pemphigus Fare in the Long Term?This marks the first long-term follow-up data from patients in the Ritux 3 trial who received rituximab as a first-line agent. |
![]()
HealthDay
23 January at 04.18 PM
Apremilast May Offer Cardiometabolic Benefit in Psoriasis PatientsFor patients with moderate-to-severe psoriasis, apremilast appears to have a neutral association with aortic vascular inflammation, generally beneficial associations with certain cardiometabolic biomarkers, and associations with reductions in visceral and subcutaneous fat, according to a study published online Sept. 21 in JAMA Dermatology. |
MedScape
23 January at 10.26 AM
Study Finds Multidisciplinary Pediatric AD Clinic BeneficialThe clinic is a collaborative effort between Rady Children's Hospital and the University of California San Diego Health Divisions of Dermatology, Allergy & Immunology, and the hospital's pharmacy. |
MedScape
23 January at 03.49 AM
Hair Creams: Do You Know the Health Risks?Some products may be easy on the hair but hard on the eyes. |
![]()
HealthDay
22 January at 10.13 PM
Older Adults Average 20.7 Total Health Care Contact Days a YearOlder adults have a mean of 20.7 total health care contact days per year, according to a study published online Jan. 23 in the Annals of Internal Medicine.Ishani Ganguli, M.D., M.P.H., from Brigham and Women's Hospital in Boston, and colleagues characterized health care contact days among community-dwelling adults aged 65 years and olde |
MedScape
22 January at 08.46 AM
Diet and Skin: What is the Evidence?There are scientific studies linking dietary factors to acne, atopic dermatitis, rosacea, and other common skin conditions. |
MedScape
22 January at 02.44 AM
Hair Loss in Children: How to Dx and Treat Different CausesTopical and systemic treatments can help children and teens regrow hair and reduce anxiety and bullying. |
![]()
HealthDay
20 January at 12.01 AM
Study IDs Risks to Offspring Associated With Prenatal Opioid ExposurePrenatal opioid exposure (POE) is associated with an increased risk for infection, eczema and dermatitis, and asthma in offspring, but it is not linked to allergies or anaphylaxis, according to a study published online Jan. 17 in JAMA Network Open.Erin Kelty, Ph.D., from the University of Western Australia in Crawley, and colleagues com |
![]()
HealthDay
19 January at 05.24 PM
Bidirectional Link ID'd for Autoimmune Disease, Perinatal DepressionThere is a bidirectional association between autoimmune disease (AD) and perinatal depression (PND), according to a study published online Jan. 9 in Molecular Psychiatry.Emma Bränn, from the Karolinska Institutet in Stockholm, and colleagues examined the bidirectional association between PND and AD using nationwide Swedish population an |
MedScape
19 January at 04.30 AM
Smoking Associated With Risk for Hair Loss Among MenThe risk for progression of androgenetic alopecia is higher among those who smoke as well, according to an analysis. |
MedScape
18 January at 03.57 AM
New Molecules Reflect Advances in Atopic DermatitisTopical formulations of JAK inhibitors could help treat moderate to severe atopic dermatitis in adults and adolescents, said one dermatologist. |
MedScape
17 January at 05.41 PM
AI-Powered Device Cleared as Noninvasive Skin Cancer TestThe handheld tool, intended for use by primary care physicians, uses spectroscopy and algorithms to evaluate skin lesions for potential cancer in a matter of seconds. |
![]()
HealthDay
17 January at 04.58 PM
Inflammation, Poverty Have Synergistic Effect on MortalityThere is a potential synergistic effect for inflammation and living in poverty with increased mortality risk for adults, according to a study published online Jan. 16 in Frontiers in Medicine.Arch G. Mainous III, Ph.D., from the University of Florida in Gainesville, and colleagues examined whether there is a synergistic effect of the |
![]()
HealthDay
17 January at 04.55 PM
Factors ID'd That Affect Medical Decision-Making in Hidradenitis SuppurativaFactors that affect medical decision-making among patients with hidradenitis suppurativa (HS) include suffering threshold, perceptions of treatment risk, treatment fatigue, understanding of the disease, and sources of information, according to a study published online Jan. 10 in JAMA Dermatology.Nicole Salame, M.D., from the Emory Un |
MedScape
17 January at 07.38 AM
Review Spotlights Effects of Epidermolysis Bullosa on BonesResearchers summarized recommendations from 13 published studies. |
MedScape
15 January at 05.32 AM
Study Estimates Post-COVID Risk for Alopecia AreataThe incidence of alopecia areata in patients with COVID-19 was significantly higher than that in the uninfected controls, in a large Korean cohort study. |
MedScape
15 January at 02.14 AM
How Should Dermatologists Confront Suspected Drug Allergies?Checking for and categorizing a suspected allergy allows physicians to draw up a management plan. |
MedScape
15 January at 02.06 AM
Etiology Elusive in Nearly 40% Cases of Urticaria in InfantsSymptoms are most likely to resolve spontaneously, researchers said. |
![]()
HealthDay
13 January at 12.12 AM
Substance Use Disorders on the Rise for Survivors of Specific CancersThe prevalence of substance use disorder (SUD) seems to be elevated among survivors of certain types of cancer, according to a study published online Jan. 11 in JAMA Oncology.Katie F. Jones, Ph.D., from VA Boston Healthcare System, and colleagues describe cancer type-specific prevalence of SUD among adult cancer survivors in a cross-sec |
![]()
HealthDay
11 January at 09.45 PM
12.8 Percent of Unique Prescribers Prescribed Topical Antifungals in 2021In 2021, 12.8 percent of unique prescribers in Medicare Part D prescribed topical antifungals, with about 6.5 million topical antifungal prescriptions filled, at a total cost of $231 million, according to research published in the Jan. 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.< |
![]()
HealthDay
11 January at 09.34 PM
Affordable Care Act Sees Record Number of Americans Signing UpWith only days left before open enrollment closes, the Biden administration announced Wednesday that 20 million Americans have already signed up for health insurance under the Affordable Care Act."Today, we hit a major milestone in lowering costs and ensuring all Americans have access to quality, affordable health care. With six days left to s |
![]()
HealthDay
11 January at 04.48 PM
CDC: 5.7 Percent of Adults Lacked Reliable Transportation in 2022In 2022, 5.7 percent of adults reported lacking reliable transportation for daily living, according to a January data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.Amanda E. Ng, Ph.D., M.P.H., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues u |
MedScape
11 January at 02.53 AM
What Factors Affect Treatment Decisions in Patients With HS?Dermatologists can empower patients to make informed, meaningful treatment choices, the authors said. |
MedScape
11 January at 12.37 AM
Probiotics, Other Supplements May Benefit Patients With AcneMyo-inositol is among the other supplements, with evidence showing they can help in patients with acne, experts said at an integrative dermatology meeting. |
MedScape
10 January at 05.30 AM
Clascoterone Efficacy for Acne Increased Over Time: AnalysisResearchers integrated data from two pivotal trials and a long-term extension study. |
MedScape
10 January at 05.30 AM
Clascoterone Efficacy or Acne Increased Over Time: AnalysisResearchers integrated data from two pivotal trials and a long-term extension study. |
MedScape
09 January at 01.45 AM
AAAAI/ACAAI Task Force Updates AD Management GuidelinesThe guidelines include 25 recommendations and address optimal use of treatments, including topical and systemic treatments, bleach baths, dietary elimination, allergen immunotherapy, and phototherapy. |
MedScape
08 January at 09.57 AM
Study Identifies CV Comorbidities Linked to DermatomyositisThe results "represent potential areas for preventative intervention," the researchers wrote. |
![]()
HealthDay
08 January at 04.59 AM
Suicide Risk Increased for Some U.S. Health Care WorkersRegistered nurses, health technicians, and health care support workers have an increased risk for suicide compared with non-health care workers, according to a study published in the Sept. 26 issue of the Journal of the American Medical Association.Mark Olfson, M.D., M.P.H., from Columbia University and the New York State Psychiatric |
![]()
HealthDay
07 January at 04.59 AM
U.S. Safety-Net Providers Report Moral Distress in Early PandemicMoral distress during the first nine months of the pandemic was reported by a majority of clinicians working in U.S. safety net practices, according to a study published online Aug. 25 in BMJ Open.Donald E. Pathman, M.D., M.P.H., from the University of North Carolina at Chapel Hill, and colleagues examined causes and levels of moral dis |
![]()
HealthDay
07 January at 04.59 AM
Child Care Stress Affects Health, Work of U.S. HCWs During PandemicChild care stress (CCS) during the pandemic is associated with anxiety, depression, burnout, intent to reduce hours, and intent to leave among health care workers (HCWs), according to a study published online July 18 in JAMA Network Open.Elizabeth M. Harry, M.D., from the University of Colorado in Aurora, and colleagues assessed whether |
![]()
HealthDay
07 January at 04.59 AM
COVID-19 Pandemic Tied to Burnout in Health Care ProfessionalsThe COVID-19 pandemic is associated with higher burnout among health care professionals (HCPs), particularly patient-facing HCPs, according to a study published online Sept. 27 in BJPsych Open.Vikas Kapil, M.B.B.S., Ph.D., from the Queen Mary University of London, and colleagues longitudinally examined mental health in 1,574 HCPs vers |
MedScape
05 January at 06.52 PM
FDA Gives Nod to Berdazimer Gel for Molluscum ContagiosumThe topical treatment is expected to be commercially available in the second half of 2024. |
MedScape
05 January at 05.25 AM
Impact of Pregnancy on Rosacea Unpredictable, Study SuggestsNearly half of study participants reported that their rosacea worsened when they were pregnant. |
MedScape
05 January at 05.23 AM
Expert Highlights Biologics in the Pipeline for EczemaDr David Rosmarin reviewed several biologics in clinical trials that target interleukin-4 and other receptors. |
MedScape
04 January at 07.59 AM
US Dermatologic Drug Approvals Rose Between 2012 and 2022Of the 52 new drugs approved in the past decade, 21% were categorized as first in class, but more innovations are needed for skin diseases with unmet therapeutic needs, the authors said. |
![]()
HealthDay
04 January at 04.59 AM
Stress-Management Interventions May Aid Health Care WorkersStress-management interventions may help individual health care workers over the short term, according to research published online May 12 in the Cochrane Database of Systematic Reviews.Sietske J. Tamminga, Ph.D., from the University of Amsterdam, and colleagues conducted a systematic review to evaluate the effectiveness of stress-red |
MedScape
04 January at 02.06 AM
Assessing Patients With AD: Tools to Use in the Office"It can be overwhelming because there are many choices but so little time," says Dr Jonathan Silverberg, of George Washington University, Washington, DC. |
MedScape
04 January at 01.09 AM
Experimental Topical Drug Shows Promise for AD, PsoriasisIn the phase 2 study, researchers at 34 sites in four countries randomized 104 patients with mild to moderate AD or psoriasis to receive the topical PDE4 inhibitor or a vehicle once daily for 6 weeks. |
![]()
HealthDay
03 January at 10.48 PM
Transgender, Gender-Diverse Individuals Report Acne-Related StigmaTransgender and gender-diverse individuals report experiencing acne-related stigma, according to a study published online Jan. 3 in JAMA Dermatology.Sarah Gold, from the Emory University School of Medicine in Atlanta, and colleagues conducted a mixed-methods analysis at a multidisciplinary gender center using semistructured interviews |
![]()
HealthDay
03 January at 04.04 PM
Skin Clinic Visits Increased With High Carbon Monoxide Levels Due to WildfiresAn increase in carbon monoxide (CO) levels associated with the Canadian wildfires of 2023 correlated with increased atopic dermatitis (AD), dermatitis, and eczema-related clinic visits in a Boston hospital system, according to a study published online Dec. 16 in Dermatology and Therapy.Kathyana P. Santiago Mangual, from Massachusetts |
MedScape
03 January at 01.14 AM
5-Year Safety Data From Upadacitinib Trials ReportedUpadacitinib trials in atopic dermatitis have included diverse patient groups with varying risk factors, according to Dr Christopher Bunick. |
MedScape
03 January at 01.14 AM
5-Year Safety Data From Upadacitinib Trials ReportedUpadacitinib trials in atopic dermatitis have included diverse patient groups with varying risk factors, according to Dr Christopher Bunick. |
![]()
HealthDay
30 December at 04.59 AM
Model Predicts New Psoriatic Arthritis in People With PsoriasisThe development of psoriatic arthritis (PsA) can be predicted with reasonable accuracy for psoriasis patients, according to a study published online Aug. 9 in Arthritis & Rheumatology.Lihi Eder, M.D., Ph.D., from University of Toronto, and colleagues developed a risk prediction model (<a href="http://sharpmindtill120.x10host.co |
![]()
HealthDay
29 December at 04.10 PM
Biological Agent Trials for Psoriasis Rarely Include Patient ImagesFew randomized controlled trials involving biological agents for psoriasis treatment include patient images, according to a review published online Nov. 15 in the Journal of Dermatological Treatment.Sam Polesie, M.D., Ph.D., from the University of Gothenburg in Sweden, and colleagues conducted a systematic review to assess the proportio |
MedScape
29 December at 11.05 AM
Conjunctivitis: How Common Is It in Patients on Dupilumab?Adults with AD have a significant and disease severity–dependent increased risk of developing ocular surface diseases, including conjunctivitis and keratitis. |
![]()
HealthDay
28 December at 05.02 PM
Updated Guidelines Released for Management of Atopic DermatitisIn updated guidelines issued by the American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology, and published online Dec. 17 in the Annals of Allergy, Asthma & Immunology, recommendations are presented for gaining and maintaining control of atopic dermatitis (AD).Derek K. Chu, M.D., Ph.D. |
![]()
HealthDay
26 December at 10.37 PM
More Than Half of U.S. Medical Interns Experience Sexual HarassmentMore than half of U.S. medical interns report experiencing sexual harassment, according to a research letter published online Dec. 26 in JAMA Network Open.Elizabeth M. Viglianti, M.D., from the University of Michigan in Ann Arbor, and colleagues investigated possible institutional variation in experiences of sexual harassment amon |
MedScape
26 December at 02.14 AM
Keeping Injectable Products in Cosmetic Dermatology SafeThe rapid increase in intradermal injections of hyaluronic acid and Botox has been accompanied by an increase in side effects. |
MedScape
26 December at 01.27 AM
FDA approves topical treatment for junctional, dystrophic EBThis is the first approved treatment for wounds associated with JEB and the second for patients with DEB, following the approval of a topical gene therapy in May 2023. |
MedScape
26 December at 12.26 AM
Study Links Specific Drugs to Delusions of Parasitosis RiskResearchers conducted a case-control study of biometric and pharmaceutical data from 34 patients with delusions of parasitosis, which they compared to an age-matched control group of 53 women. |
![]()
HealthDay
22 December at 10.35 PM
One in Five New Dermatology Drugs Were First in Class Over the Past DecadeFrom 2012 to 2022, innovative dermatologic drug development increased, according to a research letter published online Dec. 20 in JAMA Dermatology.Samir Kamat, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues characterized the frequency and degree of innovation of new dermatologic drugs (topic |
MedScape
22 December at 12.24 AM
Paradoxical Eczema Risk Low With Biologic Psoriasis TxAli Al-Janabi, MA, and associates found that 273 (1%) of approximately 25,000 drug exposures in 13,699 biologic-treated patients with psoriasis were associated with paradoxical eczema. |
![]()
HealthDay
21 December at 04.51 PM
Risk for Vitiligo Increased for Transplant RecipientsTransplant recipients, especially those receiving hematopoietic stem cell transplant (HSCT), have an increased risk for vitiligo, according to a brief report published online Dec. 13 in JAMA Dermatology.Chul Hwan Bang, M.D., Ph.D., from the Catholic University of Korea in Seoul, and colleagues conducted a population-based cohort study |
MedScape
21 December at 09.28 AM
Evaluating Aesthetic Concerns Among Hispanic, Latinx WomenTo date, the aesthetic needs of Hispanic/Latinx patients, the second largest ethnic group in the United States, have been poorly understood. |
![]()
HealthDay
21 December at 04.59 AM
Air Pollution Tied to Multimorbidity Status, SeverityExposure to air pollution is associated with having multimorbid, multiorgan conditions, according to a study published online Dec. 2 in Frontiers in Public Health.Amy Ronaldson, Ph.D., from King’s College London, and colleagues examined associations between long-term air pollution exposure and multimorbidity status, severity, and pat |
![]()
HealthDay
20 December at 11.11 PM
Osteoporosis Risk Increased With Long-Term Topical Corticosteroid ExposureThe risk for osteoporosis and major osteoporotic fracture (MOF) is increased in association with long-term exposure to topical corticosteroids (TCSs), according to a study published online Dec. 20 in the Journal of the European Academy of Dermatology and Venereology.Bing-Jun Hsieh, from the National Taiwan University Hospital in Taip |
![]()
HealthDay
20 December at 10.02 PM
Burnout, Lack of Fulfillment Linked to Physician Intention to LeaveBurnout, lack of professional fulfillment, and other well-being-linked factors are associated with intention to leave (ITL) among physicians, according to a study published online Dec. 15 in JAMA Network Open.Jennifer A. Ligibel, M.D., from the Dana-Farber Cancer Institute in Boston, and colleagues describe the prevalence of burnout, |
MedScape
20 December at 02.21 AM
Reducing CVD Morbidity and Mortality in Psoriasis and PsAOnly a minority of patients with psoriatic disease know about their increased risks. |
![]()
HealthDay
19 December at 04.58 PM
Artificial Intelligence Models Improve Clinicians' Diagnostic AccuracyStandard artificial intelligence (AI) models improve diagnostic accuracy, but systematically biased AI models reduce this accuracy, according to a study published in the Dec. 19 issue of the Journal of the American Medical Association.Sarah Jabbour, from the University of Michigan in Ann Arbor, and colleagues examined the impact of sys |
MedScape
18 December at 04.46 PM
Roflumilast Foam Gets Nod for Seborrheic DermatitisPatients in the roflumilast group showed significant improvements in all secondary endpoints, including itching, scaling, and erythema. |
![]()
HealthDay
18 December at 04.25 PM
Risk for Skin Cancer Increased for Patients With Lower Extremity LymphedemaPatients with lower extremity (LE) lymphedema have an increased risk for skin cancer, especially basal cell carcinoma, according to a study published online in the November issue of Mayo Clinic Proceedings.Nimay C. Anand, M.D., from Meharry Medical College in Nashville, Tennessee, and colleagues conducted a retrospective cohort study in |
MedScape
18 December at 02.18 PM
How Does Lebrikizumab Perform Across Different Subgroups?Key eligibility criteria for both trials included adults or adolescents with a diagnosis of AD as defined by the AAD consensus criteria, for at least 1 year prior to screening. |
MedScape
18 December at 02.06 PM
GVHD Raises Vitiligo Risk in Transplant Recipients"The findings suggest that early detection and management of vitiligo lesions can be improved by estimating the likelihood of its development in transplant recipients..." |
MedScape
18 December at 03.37 AM
Pilot Study Educates Barbers About Pseudofolliculitis BarbaeIn the study, barbers received questionnaires before and after an educational session on the recognition, cause, prevention, and treatment of PFB, which disproportionately affects Black men. |
![]()
HealthDay
15 December at 08.44 PM
Efficacy Shown for New Melanoma Therapeutic VaccineIn a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly skin cancer.People with advanced melanomas who received the vaccine plus Merck's cancer drug Keytruda were 49 percent less likely to die or have their cancer return after three yea |
MedScape
15 December at 05.16 PM
FDA Approves Tralokinumab for Treating Eczema in AdolescentsIt is the first treatment for pediatric patients with moderate-to-severe atopic dermatitis that specifically targets the interleukin (IL)-13 cytokine. |
![]()
HealthDay
15 December at 12.00 AM
More Senior Physicians See Fewer Underserved PatientsSenior physicians treat fewer traditionally underserved patients than their junior colleagues within the same practices, according to a research letter published online Dec. 13 in JAMA Network Open.Hannah T. Neprash, Ph.D., from University of Minnesota School of Public Health in Minneapolis, and colleagues examined the associatio |
MedScape
14 December at 05.00 PM
Disease Control Elusive for Many Patients on AD TherapiesA significant number of patients with moderate to severe atopic dermatitis (AD) failed to achieve adequate disease control with systemic therapies over 12 months, indicating a substantial degree of "therapeutic inertia." |
![]()
HealthDay
14 December at 05.00 PM
Blacks More Likely to Have Disseminated Manifestations of Lyme DiseaseBlack patients are more likely to be diagnosed with disseminated manifestations of Lyme disease (LD) and experience longer time to appropriate treatment, according to a research letter published online Dec. 12 in JAMA Network Open.Samuel J. Starke, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues |
MedScape
12 December at 05.03 PM
Acne Stigma Persists Across Social and Professional SettingsIndividuals with severe acne were considered less attractive, less worthy of friendship, and less likely to be hired for a job compared with those who did not have acne. |
![]()
HealthDay
12 December at 04.05 PM
ChatGPT Shows Poor Performance in Answering Drug-Related QuestionsChatGPT provided no response or incomplete or wrong answers to nearly three-quarters of drug-related questions reviewed by pharmacists, according to a study presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting, held from Dec. 3 to 7 in Anaheim, California.Sara Grossman, Pharm.D., from Long Island University in |
MedScape
12 December at 12.00 PM
Bimekizumab Promising for Palmoplantar Pustular PsoriasisPPP is a type of pustular psoriasis that remains a treatment challenge, and available treatments for palmoplantar plaque psoriasis with pustules also "remain unsatisfactory." |
![]()
HealthDay
11 December at 04.46 PM
Barbers Can Partner With Dermatologists to Augment Pseudofolliculitis Barbae CareAn educational intervention targeted at barbers substantially increases knowledge regarding the causes, prevention, and treatment of pseudofolliculitis barbae (PFB), according to a research letter published online Dec. 6 in JAMA Dermatology.Xavier Rice, M.D., from the University of Texas Medical Branch in Galveston, and colleagues |
MedScape
11 December at 06.13 AM
Study Eyes Melanoma Characteristics in AI/AN PopulationThe primary site with the highest mortality risk was the trunk. |
MedScape
08 December at 05.21 PM
Tape Strips Detect Hidradenitis Suppurativa Biomarkers"Tape strips can provide important clues to when and which drugs to use in HS in patients with both early and late disease, which can change clinical practice." |
MedScape
08 December at 04.28 PM
Combined Rituximab + Omalizumab Promising for Refractory BPBullous pemphigoid has high morbidity and mortality, especially in people with comorbidities common to older adults, yet no Food and Drug Administration–approved therapies for BP exist. |
![]()
HealthDay
07 December at 10.56 PM
Stigmatizing Attitudes Identified Toward Individuals With AcneStigmatizing attitudes toward individuals with acne are observed across a range of social and professional scenarios, according to a study published online Dec. 6 in JAMA Dermatology.Ali Shields, from Drexel University College of Medicine in Philadelphia, and colleagues conducted a cross-sectional internet survey study to explore the d |
![]()
HealthDay
07 December at 10.40 PM
White House Looks to Curb Big Pharma's Sky-High Drug PricesIn a push for lower drug prices, the Biden administration is warning pharmaceutical companies that it might use its authority to cancel patent protections if a medication is too expensive. Federal law allows the government to grant patent licenses if taxpayer dollars were used in the development of inventions -- including drugs.In a <a href="ht |
MedScape
07 December at 05.19 PM
Patients With hEDS Report Skin Laxity, ScarringFollicular occlusion, mast cell disease, and eczema were common presentations among patients with hypermobile Ehlers Danlos syndrome. |
![]()
HealthDay
06 December at 10.59 PM
Many Patients of Color Expect and Prepare for Unfair Health CareMinorities often feel a deep sense of dread before doctor appointments, and some even try to dress especially well for their visit to try and ward off the possibility they will face insults or unfair care. According to a new poll conducted by hea |
MedScape
06 December at 07.01 PM
How Can Dermatologists Improve Cancer Care?Dermatologists play a key role on interdisciplinary treatment teams. |
MedScape
06 December at 04.30 PM
FDA Mandates Changes to iPLEDGE Program for IsotretinoinIsotretinoin manufacturers have 6 months to make five changes to existing iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) requirements for isotretinoin. |
MedScape
05 December at 06.56 PM
Hope Emerges for Patients With Rare Skin Disorder"A new framework for thinking about and treating these diseases is emerging." |
![]()
HealthDay
04 December at 10.24 PM
No Increased Suicide Risk Observed for Isotretinoin UsersIsotretinoin users do not have an increased risk for suicide or psychiatric disorders and may have a lower risk for suicide attempts, according to a review published online Nov. 29 in JAMA Dermatology.Nicole Kye Wen Tan, from the National University of Singapore School of Medicine, and colleagues clarified the absolute and relative risks |
MedScape
04 December at 08.05 PM
What's New in Acne Treatment?Advances in acne care include the use of light-based devices. |
MedScape
04 December at 05.39 PM
Analysis Supports Link Between Psoriasis and OSASeveral hypotheses may explain the connection, such as the presence of inflammatory mediators and nocturnal cytokine secretion, according to the authors. |
MedScape
03 December at 05.25 PM
New Tools Available to Help Diagnose Skin CancerEmerging technologies aim to improve skin cancer diagnosis without biopsies. |
MedScape
02 December at 12.19 PM
Misdiagnoses Among Challenges in Managing Cutaneous LymphomaAlthough predictive tools to identify those at risk of disease progression are in their infancy, the development of such tools is crucial for improving patient outcomes. |
![]()
HealthDay
01 December at 05.00 PM
Ichthyosis Tied to Increased Risk of Depression, AnxietyIchthyosis is associated with increased likelihood of depression and anxiety, according to a research letter published online Oct. 18 in the Journal of the American Academy of Dermatology. Gloria Chen, from the Yale School of Medicine in New Haven, Connecticut, and colleagues investigated the relationship between ichthyosis and |
![]()
HealthDay
01 December at 05.00 PM
Ichthyosis Tied to Increased Risk for Depression, AnxietyIchthyosis is associated with an increased likelihood of depression and anxiety, according to a research letter published online Oct. 18 in the Journal of the American Academy of Dermatology. Gloria Chen, from the Yale School of Medicine in New Haven, Connecticut, and colleagues investigated the relationship between ichthyosis |
MedScape
01 December at 10.49 AM
Novel Subcutaneous Biologics Show Promise in ADPatients with moderate to severe atopic dermatitis could soon have more therapeutic options, with monoclonal antibodies targeting novel immune pathways that reduce disease severity, suggest two trials. |
MedScape
01 December at 08.10 AM
Meta-Analysis: Suicide Risk Not Increased With IsotretinoinIn fact, those treated with the drug for severe acne may have a lower risk for suicide attempts 2-4 years after treatment, according to the study authors. |
MedScape
30 November at 02.31 PM
Dietary Supplements May Play a Role in Managing VitiligoDietary supplements have a role in the integrative treatment of vitiligo, largely through antioxidant pathways and as an adjuvant to phototherapy. |
MedScape
30 November at 01.34 PM
Pilonidal Disease: Study Finds Laser Hair Removal BeneficialThe study compared laser epilation plus standard of care with standard care alone for patients aged 11-20 years with pilonidal disease. |
![]()
HealthDay
29 November at 04.37 PM
AI Accurate in Diagnosing Suspicious Skin LesionsA mobile phone-powered artificial intelligence (AI) technology is effective for diagnosing suspicious skin lesions, according to a study published in the October issue of The Lancet Digital Health.Scott W. Menzies, Ph.D., from the University of Sydney, and colleagues compared the accuracy of AI algorithms and clinicians for the |
MedScape
28 November at 07.24 PM
Tapinarof Effective for AD in Patients as Young as 2 yearsTapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults. |
MedScape
28 November at 05.52 PM
Nail Psoriasis in Black Patients Often OverlookedUnderrepresentation of Black patients with psoriasis in trials and textbooks might partially explain why clinicians are slow to recognize nail involvement, even after psoriasis has been diagnosed. |
MedScape
28 November at 02.18 PM
HS: Positive Results Reported With Anti-IL17A/F TherapiesOne of the trials evaluated a nanobody inhibitor, sonelokimab, a molecule with a substantially smaller size than traditional monoclonal antibodies. |
MedScape
28 November at 01.56 PM
At 52 Weeks, Hair Growth Still Climbing on DeuruxolitinibWith response curves still climbing at follow-up to date, the results are 'truly, truly remarkable.' |
MedScape
23 November at 09.06 AM
Parent Concerns a Factor When Treating Patients With ADFor a parent whose child has an inflammatory skin disease, pigmentation changes, rather than inflammation, might be the reason that he or she brought the child to the clinician. |
![]()
HealthDay
22 November at 10.51 PM
Incidence of Local-Stage Cancers Decreased From 2019 to 2022From 2019 to 2020, the incidence of local-stage disease decreased significantly for 19 of 22 cancer types compared with stable year-over-year changes pre-COVID-19, according to a study published online Nov. 16 in the International Journal of Cancer.Elizabeth J. Schafer, M.P.H., from the American Cancer Society in Atlanta, and colleag |
MedScape
22 November at 11.08 AM
Questionnaire Measures Patient Satisfaction With Acne TxA dermatology-specific questionnaire assessed three aspects of treatment in patients with acne. |
MedScape
20 November at 06.20 AM
Lebrikizumab Gets the Nod in the EU for Atopic DermatitisLebrikizumab, an interleukin-13 inhibitor, is not yet approved in the United States. |
MedScape
17 November at 05.48 AM
New Consensus Guide on Rare Drug Hypersensitivity ReactionExperts provided parameters to help clinicians, but they acknowledged the limited evidence base for drug reaction with eosinophilia and systemic symptoms. |
![]()
HealthDay
16 November at 05.00 PM
Recommendations Developed for Atopic Dermatitis TherapiesIn updated guidelines issued by the American Academy of Dermatology and published online Nov. 7 in the Journal of the American Academy of Dermatology, recommendations are presented for use of phototherapy and systemic therapies for atopic dermatitis (AD) and include strong endorsements of monoclonal antibodies and Janus kinase inhib |
MedScape
15 November at 05.53 AM
Isothiazolinone Allergy Common, Often to Multiple AllergensMany people in North America appear to be allergic to one or more of a family of preservatives used in personal care products and household cleaners implicated in the global spread of allergic contact dermatitis. |
MedScape
14 November at 06.21 PM
LE Lymphedema Associated With Greater Skin Cancer RiskIn the retrospective study, patients with lower extremity lymphedema were at an almost twofold greater risk for skin cancer compared with matched controls. |
![]()
HealthDay
14 November at 04.15 PM
Acupuncture Offers Some Benefit in Chronic Spontaneous UrticariaFor patients with chronic spontaneous urticaria (CSU), acupuncture produces a greater improvement in the Weekly Urticaria Activity Score (UAS7), although the difference is not clinically significant, according to a study published online Nov. 14 in the Annals of Internal Medicine.Hui Zheng, M.D., Ph.D., from the Chengdu University of T |
MedScape
13 November at 08.47 PM
AAD Updates Guidelines for Managing ADThe guidelines cover approved and off-label uses of systemic therapies and phototherapy, including new treatments that have become available since the last guidelines were published in 2014. |
MedScape
13 November at 05.00 PM
Dermatopathologists Make More Higher-Grade Dx of LesionsThe findings "could in part play a role in the rising incidence of early-stage melanoma with low risk of progression or patient morbidity, thereby contributing to increasing rates of overdiagnosis." |
![]()
HealthDay
13 November at 04.54 PM
ACAAI: Parents, Patients Offer Theories on Causes/Origins of Food AllergiesParents and adult patients with food allergy (FA) believe that factors such as diet, genetics, family history, and infection are associated with FA development, according to a study presented at the annual meeting of the American College of Allergy, Asthma & Immunology, held from Nov. 9 to 13 in Anaheim, California.Rachelle Liu, from the Nor |
MedScape
13 November at 02.15 PM
Prurigo Nodularis Dx Delay in Skin Types Gains SignificancePatients with darker skin types tend to have larger nodules that might vary in shape relative to lighter skin types, according to Shawn Kwatra, MD. |
MedScape
13 November at 12.36 PM
Palmoplantar Pustulosis: Treatment ChallengesWhen it comes to pustular disease localized to the hands and feet, treatment options have only modest efficacy, according to speakers at the annual National Psoriasis Foundation research symposium. |
MedScape
09 November at 12.50 PM
Incipient Ulceration May Affect Prognosis in Primary MelanomaAssigning a lower-risk pathologic T stage to such melanomas may not be appropriate, the study authors conclude. |
MedScape
09 November at 09.27 AM
Actinic Keratoses May Predict Skin Cancers in Older AdultsA retrospective cohort study showed increased absolute and relative risks for skin cancers up to 5 years after an AK diagnosis. |
MedScape
08 November at 05.43 PM
Sharps Injuries Are Common Among Mohs Surgeons, Survey FindsAmong respondents who sustained a sharps injury, 44.1% did not report them. |
MedScape
08 November at 05.13 PM
BDD: Diagnosis Guidelines to be Published in EuropeThe guidelines support uniform screening for BDD in all patients prior to cosmetic procedures. |
MedScape
08 November at 04.48 PM
Teasing Apart Multiple Biologic Failure in Psoriasis, PsA'Tough-to-treat psoriasis remains a challenge despite newer therapies ... Why do we still have this sub-population of patients who seem to be refractory?' |
MedScape
08 November at 01.50 PM
Vitiligo: 'Impressive' Results for Povorcitinib, BaricitinibSubstantial facial and total body repigmentation in patients with nonsegmental vitiligo was achieved in separate trials of povorcitinib and baricitinib plus phototherapy. |
MedScape
06 November at 04.02 PM
What Can Clinicians Do to Treat Patients With Vitiligo?Dismissing the idea that nothing can be done for these patients, a dermatologist reviews the current and emerging therapeutic options. |
![]()
HealthDay
03 November at 11.00 PM
Critics Slam Updated Infection Control Recommendations for HospitalsAdvisors to the U.S. Centers for Disease Control and Prevention are expected to approve new draft guidelines for hospital infection control this week, the first update since 2007.But health care workers worry whether the guidelines, which suggest that surgical masks are as good as N-95 masks at preventing the spread of respiratory infections duri |
MedScape
03 November at 04.43 PM
Topical Ivermectin Study Sheds Light on Dysbiosis in RosaceaStudy findings show that ivermectin reduces the density of Demodex folliculorum in rosacea lesions, but the skin microbiome takes time to recover. |
![]()
HealthDay
03 November at 03.28 PM
AI Getting Better at Detecting Skin CancerArtificial intelligence (AI) is increasingly accurate in detecting skin cancer, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Oct. 11 to 14 in Berlin.Kashini Andrew, M.B.B.S., from the University Hospitals Birmingham NHS Foundation Trust in the United Kingdom, and colleagues |
MedScape
03 November at 10.12 AM
Ready to Start Engaging on Social Media?In the opinion of Swati Kannan, MD, deciding whether or not to establish a presence on social media starts with a gut-check about your intentions. |
![]()
HealthDay
02 November at 11.00 PM
FDA Approves Wezlana for Multiple Inflammatory DiseasesThe U.S. Food and Drug Administration has approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory diseases. The approval includes indications for adults with moderate-to-severe plaque psoriasis who are candidates for phototherapy or systemic therapy, active psoriatic a |
![]()
HealthDay
02 November at 03.40 PM
Skin Diseases Pose a Psychosocial BurdenSkin diseases can cause a psychosocial burden and feelings of stigmatization, according to a study published online Oct. 8 in the Journal of the European Academy of Dermatology and Venereology.Paolo Gisondi, M.D., from the University of Verona in Italy, and colleagues evaluated the burden of the most common dermatological diseases |
![]()
HealthDay
01 November at 10.10 PM
Interventions to Redesign Patient Care Do Not Improve OutcomesInterventions to redesign care for hospitalized patients are not associated with improved patient outcomes, according to a study published online Oct. 31 in the Annals of Internal Medicine.Kevin J. O'Leary, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues examined the effect of intervention |
![]()
HealthDay
01 November at 06.54 PM
More Than Half of U.S. Adults Use Internet to Look for Health, Medical InformationMore than half of adults used the internet to look for health or medical information during July to December 2022, with higher prevalence among women than men, according to an October data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.Xun Wang and Robin A. Cohen, Ph.D., from the Na |
![]()
HealthDay
01 November at 03.16 PM
AAP: Children Most Likely to Present to ED With Burns From Hair Styling ToolsChildren younger than 10 are most likely to present to the emergency department with burn injuries sustained from hair styling tools, especially hair curlers and curling irons, according to a study presented at the annual meeting of the American Academy of Pediatrics, held from Oct. 20 to 24 in Washington, D.C.Brandon L. Rozanski, M.D., from T |
MedScape
01 November at 02.29 PM
CV, VTE Risk Not Seen in Derm Studies of JAK Inhibitors'There remains a knowledge gap regarding the risk of JAK inhibitor use and VTE and/or MACE in the dermatologic population,' the study authors wrote. |
MedScape
01 November at 10.42 AM
Study Finds Ruxolitinib Effective, Safe for Children With ADThere were no significant safety signals in the younger pediatric population, and 'no treatment-emergent adverse events suggestive of systemic JAK inhibition,' Dr Lawrence Eichenfield said. |
MedScape
31 October at 08.27 PM
FDA Approves Secukinumab for Adults With HSThis marks the second FDA-approved agent for the condition, and the first IL-17A inhibitor. |
MedScape
31 October at 06.37 PM
¬¬Study Spotlights Features of Infantile Hemangioma SubsetDetailed reports on this patient population are sparse and limited to case reports and small case series. |
MedScape
31 October at 06.37 PM
Study Spotlights Features of Infantile Hemangioma SubsetDetailed reports on this patient population are sparse and limited to case reports and small case series. |
MedScape
30 October at 04.59 PM
Dupilumab-Associated Lymphoid Reactions Require CautionRetrospective study identifies potential for misdiagnosed mycosis fungoides and for dupilumab to fuel cutaneous lymphoid reactions that mimic mycosis fungoides in patients with atopic dermatitis. |
![]()
HealthDay
30 October at 03.58 PM
Lymphoid Reaction Observed in Eczema Patients Receiving DupilumabFor adults with atopic dermatitis (AD) receiving dupilumab treatment, a reversible lymphoid reaction (LR) has been observed, which mimics cutaneous T-cell lymphoma (CTCL), according to a study published online Oct. 18 in JAMA Dermatology.Celeste M. Boesjes, M.D., from the University Medical Center Utrecht in the Netherlands, and colleag |
![]()
HealthDay
27 October at 10.29 PM
Teens With Atopic Dermatitis More Likely to Experience BullyingAdolescents with atopic dermatitis have higher odds of being bullied at higher frequency after adjustment for demographics, atopic comorbidities |
MedScape
27 October at 05.50 PM
Multicenter HS Study Expanding to More Clinical SitesAmong the objectives of the study, which aims to enroll 8000 patients with HS, is to collect biospecimens from patients for translational studies. |
MedScape
27 October at 04.43 PM
Acne: Study Evaluates the Evidence for NutraceuticalsDespite the many acne treatments available, 'patients may be interested in natural and complementary therapies as either an adjunctive or an alternative to prescription medications,' the authors said. |
![]()
HealthDay
26 October at 09.17 PM
Affording Health Care Now a Struggle for Half of Americans: PollMore than half delayed or skipped care because of concerns about costs |
![]()
HealthDay
26 October at 03.43 PM
Nemolizumab Improves Symptoms in Prurigo NodularisTreatment efficacy seen in primary end points of itch response and Investigator's Global Assessment response |
MedScape
25 October at 02.15 PM
Nemolizumab Promise for Prurigo Nodularis ContinuesResults from OLYMPIA 1 provide further support for nemolizumab as a potential first-in-class prurigo nodularis treatment; in another study, a JAK inhibitor was beneficial in patients with PN. |
MedScape
25 October at 01.05 PM
GW Teledermatology Model Expands to Four Underserved AreasFour institutions will receive grants to implement the model, which involved partnering with a local organization to provide an entry point for individuals in areas with limited access to medical care. |
MedScape
25 October at 12.11 PM
FDA Approves Triple Combination Topical Treatment for AcneThe product combines an antibiotic, a retinoid, and an antibacterial in a gel formulation. |
MedScape
25 October at 11.00 AM
Bullying More Prevalent Among Adolescents With ADData were collected from adult caregivers of more than 3200 adolescents in the United States. |
MedScape
25 October at 06.24 AM
Shared Decision-Making Low in Patients With PsoriasisThe study findings underscore the importance of enhancing clinician-patient communication, the authors say. |
MedScape
24 October at 01.15 PM
Strategy Shows Promise for Psoriasis Remission in Early StudyThe study is investigating whether high-dose IL-23 inhibition can target resident memory T cells and thereby induce long-term remission. |
MedScape
24 October at 12.46 PM
Oleogel-S10 Reduces Daily Dressing Need in EB StudyOleogel-S10 reduced the need for daily dressing changes compared with a control gel in patients with epidermolysis bullosa, according to a further analysis of data from the phase 3 EASE study. |
MedScape
23 October at 01.47 PM
FDA Calls for More Data on Dupilumab for CSU IndicationIn a letter, the FDA stated that additional efficacy data are required to support an approval for chronic spontaneous urticaria (CSU), according to the manufacturers of dupilumab. |
MedScape
20 October at 01.01 PM
AI Can Flag Skin Cancer With Near-Perfect AccuracyArtificial intelligence could help dermatologists catch skin cancer faster and triage patients. |
MedScape
19 October at 01.29 PM
Review Estimates Acne Risk With JAK Inhibitor TherapyA systematic review and meta-analysis with more than 10,000 individuals showed a significant increase in acne associated with JAK inhibitors. |
MedScape
18 October at 01.44 PM
FDA Approves Bimekizumab for Plaque Psoriasis in AdultsBimekizumab is the first IL-17A and IL-17F inhibitor approved by the FDA for adults with psoriasis. |
MedScape
18 October at 12.11 PM
Recombinant IL-2 Shows Potential in Atopic Dermatitis"This is the first study to demonstrate the therapeutic potential of rezpegaldesleukin," said Jonathan Silverberg, MD, PhD, MPH, who presented results of a phase 1b study. |
MedScape
13 October at 01.48 PM
Once-Weekly Topical Therapy Shows Promise for AcneResearchers say the novel once-weekly application could improve patient adherence. |
MedScape
13 October at 01.31 PM
Patients With Psoriasis Lose Weight With Roflumilast: StudyOral roflumilast not only appears to improve skin symptoms, but it could also help with weight loss, results of the phase 2 PSORRO study suggest. |
MedScape
12 October at 04.23 PM
Novel Triple Threat Approach to Acne Beats PlaceboA topical therapy that combines three acne medications applied once a day showed efficacy superior to a vehicle in two phase 3 studies of children and adults with moderate to severe acne. |
MedScape
12 October at 12.34 PM
Topical Botanical Drug Coacillium Curbs Childhood AlopeciaGreater improvement in Severity of Alopecia Tool (SALT) scores at 24 weeks were seen with coacillium vs placebo, which lasted after treatment stopped. |
MedScape
11 October at 03.48 PM
Analysis Spotlights Economic Burden of Vitiligo in the USDetermining medical costs will help identify the main expenditure predictors and spending patterns, according to the authors. |
MedScape
11 October at 11.01 AM
Imaging Test Helps Detect Craniofacial Morphea ProgressionAssessment of images also showed strong interrater reliability in patients with Fitzpatrick skin types IV to VI. |
MedScape
09 October at 03.27 PM
Palmoplantar Psoriasis More Common Among Black ChildrenThe prevalence of nail, palm, and sole involvement was highest among Black children with psoriasis compared with children of other ethnicities. |
MedScape
06 October at 03.20 PM
FDA OKs Topical Roflumilast for Psoriasis in Kids Aged 6-11This marks an expanded indication for the drug, which was first approved for the same indication in July 2022 for individuals aged 12 and older. |
MedScape
04 October at 01.50 PM
Study Finds Higher Prevalence of ACD Among Children With ADMore children with AD should be evaluated for ACD and undergo patch testing, study authors say. |
MedScape
04 October at 10.21 AM
Spironolactone Effective Treatment for Women With HS, StudyThe anti-androgenic agent is used to treat HS in women, but there is a paucity of data on its efficacy and whether certain patient characteristics influence response. |
MedScape
02 October at 04.24 PM
FDA Issues Letter Regarding Lebrikizumab Review for ADThe FDA has issued a complete response letter regarding lebrikizumab, an investigational biologic for the treatment of adult and adolescent patients with moderate to severe atopic dermatitis. |
MedScape
28 September at 08.57 PM
Study Finds IBD Risk Higher in Children, Adults with ADChildren and adults with atopic dermatitis may be at increased risk for inflammatory bowel disease, researchers report. |
MedScape
28 September at 06.01 PM
A Glimpse at Devices Designed to Tackle CelluliteWhile mechanical subcision of fat septa with a scalpel or a large bore needle is a tried-and-true treatment for cellulite, other technologies have emerged as alternatives. |
MedScape
28 September at 05.31 PM
'Old School’ Laser Rx Remains Effective Rejuvenation OptionDrawbacks to fully ablative laser resurfacing include significant downtime and extensive wound care, "so it’s not for everybody," says Arisa E. Ortiz, MD. |
MedScape
27 September at 11.01 AM
|
MedScape
25 September at 05.07 PM
Study Spotlights Paucity of Black Dermatologists in AcademiaBlack faculty comprise just 18.7% of active Black dermatologists in the United States, according to a 2022 report from the Association of American Medical Colleges. |
MedScape
25 September at 02.11 PM
Thread Lifts an Option for Noninvasive Facial TighteningDowntime with thread lifts is minimal, but results are 'subtle' and 'not long lasting.' |
MedScape
21 September at 05.48 PM
Does the Number of Primary Melanomas Affect Survival?Detecting melanoma at an early stage remains the biggest influence on mortality after one or more melanomas are diagnosed, according to investigators. |
MedScape
21 September at 11.54 AM
Pain Evaluated as Pyoderma Gangrenosum Outcome MeasureAccording to researchers, this is the first minimal important difference (which can help determine whether patients are responding to treatment) that has been calculated for an ulcerative skin condition. |
MedScape
20 September at 06.00 PM
Most Adults With Alopecia Areata Untreated 1 Year After DxIn the study, two-thirds of newly diagnosed patients had received at least one treatment within the first year of diagnosis. |
MedScape
20 September at 11.00 AM
Study Confirms Psoriasis Linked to Higher Heart Disease RiskTo date, the study is the largest to explore the relationship between severe psoriasis and coronary microvascular dysfunction. |
MedScape
20 September at 01.00 AM
Study Confirms Psoriasis Linked to Higher Heart Disease RiskTo date, the study is the largest to explore the relationship between severe psoriasis and coronary microvascular dysfunction. |
MedScape
19 September at 04.46 PM
European Commission Approves Ritlecitinib for Severe AAThis makes ritlecitinib the first medicine authorized by the EC to treat individuals with severe alopecia areata as young as 12 years of age. |
MedScape
19 September at 02.55 PM
Combining Lasers to Maximize Results, Patient SatisfactionThe order of device use matters, according to Dr. Mathew Avram. |
MedScape
18 September at 01.57 PM
When Treating Scars, ‘Rehabilitation’ is the Goal"When you treat a scar, you treat the features of the scar that make it stand out." |
MedScape
15 September at 04.34 PM
CHMP Recommends Marketing of Biologic for Atopic DermatitisLebrikizumab is a monoclonal antibody that binds to cytokine IL-13, which has been implicated in driving the type-2 inflammatory loop in the skin, leading to skin barrier dysfunction. |
MedScape
14 September at 12.43 PM
High Rate of Subsequent Cancers in Merkel Cell CarcinomaIn this cohort study, researchers identified 6146 patients from 17 registries of the SEER Program who had been diagnosed with a first primary cutaneous Merkel cell carcinoma between 2000 and 2018. |
MedScape
12 September at 04.28 PM
Company Submits Supplemental NDA for Topical AD TreatmentSubmission is based on positive results from two phase 3, vehicle-controlled trials in patients ages 6 and older with mild to moderate AD. |
MedScape
11 September at 04.39 PM
Can Skin Bleaching Lead to Cancer?The use of skin-lightening products is associated with a wide range of complications. Is squamous cell carcinoma one of them? |
MedScape
07 September at 12.51 PM
Expert Reviews Use of Noninvasive Fat Removal ProceduresCoolSculpting freezes excess fat to remove it from stubborn areas via panniculitis. It accounts for about 72% of the noninvasive fat removal treatments performed in the US, according to an expert. |
MedScape
05 September at 01.51 PM
Going Into Solo Practice? An Expert Shares TipsCatherine M. DiGiorgio, MD, MS, found herself at a crossroads: stay and work for a large corporation or open a solo practice? |
MedScape
05 September at 10.10 AM
'Barbie Botox' Goes Viral but Doctors Inject CautionThe viral trend of 'Barbie Botox' has women as young as in their 20s rush for toxin-based procedures to mimic the looks of the movie's lead actress Margot Robbie. |
MedScape
31 August at 05.25 PM
Tralokinumab Safe, Effective in Older Pop With AD: AnalysisThe findings are important for the older patient population who "typically face unique treatment challenges," the authors write. |
MedScape
29 August at 04.50 PM
FDA to Step Up Oversight of Cosmetics, Assess PFASA 2022 law expanded the FDA's authority to regulate makeup, and it also set a 3-year deadline for a report on potential risk of PFAS, known as 'forever chemicals,' in cosmetics. |
![]()
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
![]()
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
![]()
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |
![]()
HealthDay
21 June at 03.38 PM
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is LowThe overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval |
Medpage Today
13 June at 06.56 PM
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?Finding a way to dissociate the activity of effector T cells from regulatory T cells could make immune checkpoint inhibitors more effective in the 60% of melanoma patients who do not benefit or develop resistance to the drugs... |
Medpage Today
08 June at 04.00 PM
Here Are the Top Supreme Court Health Cases to WatchBy early July, the Supreme Court will release its most controversial rulings for the 2023-2024 term. The Court's 6-3 conservative supermajority has already overturned Roe v. Wade, sharply limited affirmative action, expanded... |